Paul R. Fortin

Patients with systemic autoimmune diseases could not distinguish comorbidities from their index disease, Baron, M., Wither, J., Fortin, P.R., Taillefer, S., Bernatsky, S., Hudson, M., Journal of Clinical Epidemiology, 2008, 10.1016/j.jclinepi.2007.08.010

Organ manifestations influence differently the responsiveness of 2 lupus disease activity measures, according to patients' or physicians' evaluations of recent lupus activity, Fortin, P.R., Ferland, D., Abrahamowicz, M., Chang, E.R., Journal of Rheumatology, 2002

Non-Hodgkin's lymphoma in systemic lupus erythematosus, Clarke, A., St. Pierre, Y., Sturfelt, G., Nived, O., Steinsson, K., Sibley, J., Bae, S.-C., Gordon, C., Barr, S., Edworthy, S., Fortin, P.R., Gladman, D., Urowitz, M., Ginzler, E., Manzi, S., Zoma, A., Cournoyer, D., Lachance, S., Joseph, L., Boivin, J.-F., Rajan, R., Ramsey-Goldman, R., Bernatsky, S., Annals of the Rheumatic Diseases, 2005, 10.1136/ard.2004.034504

Measuring the Impact of MyLupusGuide in Canada: Results of a Randomized Controlled Study, Deborah Da Costa, Murray Rochon, J. Antonio Avina‐Zubieta, Stephanie Keeling, Ann E. Clarke, Janet E. Pope, Mark Matsos, Doug Smith, Marie Hudson, Evelyne Vinet, Christine A. Peschken, Davy Eng, Anna‐Lisa Morrison, Jodie Nimigon‐Young, Vinita Haroun, Elham Rahme, Anne‐Sophie Julien, Carolyn Neville, Paul R. Fortin, Arthritis Care & Research, 2023, 10.1002/acr.24871

The comparability of functional assessment of chronic illness therapy - Fatigue scores between cancer and systemic sclerosis, Fritzler, M., Fortin, P.R., Thorne, C., Smith, D., Rodriguez-Reyna, T.S., Robinson, D., Sutton, E., Masetto, A., Khalidi, N., Larché, M., Pope, J., Gyger, G., Thombs, B.D., Cella, D., Baron, M., Hudson, M., Levis, B., Kwakkenbos, L., Coroiu, A., Journal of Scleroderma and Related Disorders, 2017, 10.5301/jsrd.5000227

Tuberculosis of the skull, Fortin, P.R., Lebel, F., Miller, M.A., American Journal of Roentgenology, 1990, 10.2214/ajr.155.5.2120959

Autoantibodies and neuropsychiatric events at the time of systemic lupus erythematosus diagnosis: Results from an international inception cohort study, Merrill, J.T., Thompson, K., Qi, Q., Kalunian, K., Douglas, J., Font, J., Zoma, A., Khamashta, M., Petri, M., Alarcón, G.S., Sanchez-Guerrero, J., Nived, O., Sturfelt, G., Van Vollenhoven, R., Ramsey-Goldman, R., Wallace, D.J., Aranow, C., Ginzler, E., Bruce, I.N., Steinsson, K., Manzi, S., Gladman, D., Fortin, P.R., Bernatsky, S., Clarke, A., Dooley, M.A., Isenberg, D., Bae, S.C., Gordon, C., Farewell, V., Siannis, F., Urowitz, M.B., Hanly, J.G., Arthritis and Rheumatism, 2008, 10.1002/art.23218

Steroid-sparing effects of methotrexate in systemic lupus erythematosus: A double-blind, randomized, placebo-controlled trial, Zummer, M., Smith, C.D., Lacaille, D., Ferland, D., Abrahamowicz, M., Fortin, P.R., Arthritis Care and Research, 2008, 10.1002/art.24068

Systemic lupus erythematosus disease activity index 2000 responder index-50: A reliable index for measuring improvement in disease activity, Gladman, D.D., Ibañez, D., Taghavi-Zadeh, S., Ziouzina, O., Ghanem, A., Eder, L., Chandran, V., Riddell, C., Toloza, S.M., Landolt, C., Fortin, P.R., Urowitz, M.B., Touma, Z., Journal of Rheumatology, 2011, 10.3899/jrheum.101080

Impact of disease activity and cumulative damage on the health of lupus patients, Danoff, D., Clarke, A.E., Fraenkel, L., Du Berger, R., Neville, C., Abrahamowicz, M., Fortin, P.R., Lupus, 1998, 10.1191/096120398678919813

The prevalence and determinants of anti-DFS70 autoantibodies in an international inception cohort of systemic lupus erythematosus patients, Fritzler, M.J., Mahler, M., Buyon, J., Askanase, A., Jacobsen, S., Peschken, C.A., Kamen, D.L., Inanc, M., Kalunian, K.C., Lim, S.S., Ruiz-Irastorza, G., Ramos-Casals, M., Van Vollenhoven, R.F., Zoma, A.A., Nived, O., Manzi, S., Alarcón, G.S., Aranow, C., Khamashta, M.A., Ramsey-Goldman, R., Steinsson, K., Sanchez-Guerrero, J., Gladman, D.D., Fortin, P., Dooley, M.A., Bruce, I.N., Petri, M., Ginzler, E.M., Rahman, A., Isenberg, D.A., Merrill, J.T., Wallace, D.J., Bernatsky, S., Bae, S.-C., Gordon, C., Romero-Diaz, J., Urowitz, M.B., Hanly, J.G., St Pierre, Y., Clarke, A.E., Choi, M.Y., Lupus, 2017, 10.1177/0961203317692437

Headache in systemic lupus erythematosus: Results from a prospective, international inception cohort study, Farewell, V., Thompson, K., Theriault, C., Jacobsen, S., Peschken, C.A., Kamen, D.L., Inanc, M., Lim, S.S., Kalunian, K.C., Ruiz-Irastorza, G., Mackay, M., Aranow, C., Ramos-Casals, M., Van Vollenhoven, R.F., Zoma, A.A., Nived, O., Sturfelt, G.K., Manzi, S., Ramsey-Goldman, R., Khamashta, M.A., Steinsson, K., Dooley, M.A., Bruce, I.N., Alarcõn, G.S., Gladman, D.D., Fessler, B.J., Fortin, P.R., Petri, M., Merrill, J.T., Rahman, A., Isenberg, D.A., Ginzler, E.M., Wallace, D.J., Bernatsky, S., Clarke, A.E., Romero-Diaz, J., Sanchez-Guerrero, J., Bae, S.-C., Gordon, C., O'Keeffe, A.G., Urowitz, M.B., Hanly, J.G., Arthritis and Rheumatism, 2013, 10.1002/art.38106

Effect of menopause on the modified Rodnan skin score in systemic sclerosis, Fritzler, M., Fortin, P.R., Smith, D., Thorne, C., Gyger, G., Grodzicky, T., Ligier, S., Mathieu, J.-P., Sutton, E., Masetto, A., LeClercq, S., Kaminska, E., Docherty, P., Larché, M., Khalidi, N., Jones, N., Robinson, D., Markland, J., Pope, J., Baron, M., Pineau, C.A., Hudson, M., Bernatsky, S., Vinet, T., Arthritis Research and Therapy, 2014, 10.1186/ar4587

Antiphospholipid antibodies and thrombosis: Association with acquired activated protein C resistance in venous thrombosis and with hyperhomocysteinemia in arterial thrombosis, Fortin, P.R., Subang, R., Le Comte, M., Joseph, L., Chang, E.R., Busque, L., Rauch, J., Neville, C., Kassis, J., Thrombosis and Haemostasis, 2004, 10.1160/TH04-03-0138

Predictors of delay in starting radiation treatment for patients with early stage breast cancer, Freeman, C.R., Levinton, C., Zhang, G., Fortin, P.R., Ho, V., Benk, V., International Journal of Radiation Oncology Biology Physics, 1998, 10.1016/S0360-3016(98)00046-7

Peripheral Nervous System Disease in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study, Farewell, V., Theriault, C., Askanase, A., Kamen, D.L., Peschken, C.A., Jacobsen, S., Kalunian, K.C., Inanc, M., Lim, S.S., Ramos-Casals, M., Ruiz-Irastorza, G., Mackay, M., Aranow, C., van Vollenhoven, R.F., Svenungsson, E., Alarcón, G.S., Khamashta, M.A., Jonsen, A., Nived, O., Manzi, S., Zoma, A.A., Ramsey-Goldman, R., Steinsson, K., Dooley, M.A., Ginzler, E.M., Petri, M., Bruce, I.N., Gladman, D.D., Fortin, P.R., Merrill, J.T., Rahman, A., Isenberg, D.A., Wallace, D.J., Clarke, A.E., Bernatsky, S., Sanchez-Guerrero, J., Romero-Diaz, J., Bae, S.-C., Gordon, C., Urowitz, M.B., Su, L., Li, Q., Hanly, J.G., Arthritis and Rheumatology, 2020, 10.1002/art.41070

Job accommodations availability and utilization among people with lupus: An examination of workplace activity limitations and work context factors, Fortin, P.R., Su, J., Beaton, D.E., Gignac, M.A.M., Al Dhanhani, A.M., Arthritis Care and Research, 2015, 10.1002/acr.22662

Inhibition of lupus anticoagulant activity by hexagonal phase phosphatidylethanolamine in the presence of prothrombin, Fortin, P.R., Neville, C., Tannenbaum, M., Rauch, J., Thrombosis and Haemostasis, 1998, 10.1055/s-0037-1615392

Economic Evaluation of Lupus Nephritis in the Systemic Lupus International Collaborating Clinics Inception Cohort Using a Multistate Model Approach, Clarke, A.E., Farewell, V., Theriault, C., Askanase, A., Jacobsen, S., Peschken, C.A., Kamen, D.L., Inanc, M., Kalunian, K.C., Lim, S.S., Ruiz-Irastorza, G., Ramos-Casals, M., van Vollenhoven, R.F., Zoma, A.A., Jönsen, A., Nived, O., Manzi, S., Alarcón, G.S., Mackay, M., Aranow, C., Khamashta, M.A., Ramsey-Goldman, R., Sanchez-Guerrero, J., Gladman, D.D., Fortin, P.R., Bruce, I.N., Petri, M., Ginzler, E.M., Rahman, A., Isenberg, D.A., Wallace, D.J., Bernatsky, S., Bae, S.-C., Gordon, C., Romero-Diaz, J., St. Pierre, Y., Urowitz, M.B., Su, L., Hanly, J.G., Barber, M.R.W., Arthritis Care and Research, 2018, 10.1002/acr.23480

Quantitative clinical assessment of disease activity in systemic lupus erythematosus: progress report and research agenda, Snaith, L., Isenberg, D.A., Fortin, P.R., Liang, M.H., Rheumatology International, 1991, 10.1007/BF00304502

Clinical correlates of monospecific anti-PM75 and anti-PM100 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects, Salazar, G., McNearney, T.A., Zochling, J., Sahhar, J., Rischmueller, M., Patterson, K., Roddy, J., Nash, P., Lester, S., Hill, C., Fritzler, M.J., Larché, M., Fortin, P.R., Smith, D., Gyger, G., Thorne, C., LeClercq, S., Grodzicky, T., Ligier, S., Mathieu, J.-P., Sutton, E., Masetto, A., Kaminska, E., Docherty, P., Khalidi, N., Jones, N., Robinson, D., Markland, J., Baron, M., Wang, M., Pope, J., Tatibouet, S., Mayes, M.D., Assassi, S., Nikpour, M., Stevens, W., Walker, J., Proudman, S., Hudson, M., Wodkowski, M., Autoimmunity, 2015, 10.3109/08916934.2015.1077231

Breast cancer in systemic lupus erythematosus (SLE): receptor status and treatment, Bernatsky, S., Yelin, E.H., Wallace, D.J., Bae, S.C., Fortin, P.R., Ginzler, E., Petri, M., Romero-Diaz, J., Nived, O., Gladman, D., Urowitz, M.B., Tessier Cloutier, B., Foulkes, W., Clarke, A.E., Ramsey-Goldman, R., Chan, K., Lupus, 2018, 10.1177/0961203317713146

Accumulation of coronary artery disease risk factors over three years: Data from an international inception cohort, Stoll, T., Kalunian, K., Aranow, C., Van Vollenhoven, R., Font, J., Maddison, P., Nived, O., Sturfelt, G., Zoma, A., Ramsey-Goldman, R., Khamashta, M., Manzi, S., Bruce, I., Dooley, M.A., Petri, M., Steinsson, K., Alarcón, G.S., Merrill, J., Ginzler, E., Isenberg, D., Wallace, D., Hanly, J., Gordon, C., Bernatsky, S., Clarke, A., Bae, S., Sanchez-Guerrero, J., Fortin, P., Ibañez, D., Gladman, D., Urowitz, M.B., Arthritis Care and Research, 2008, 10.1002/art.23353

Risk for incident arterial or venous vascular events varies over the course of systemic lupus erythematosus, Fortin, P.R., Clarke, A.E., Neville, C., Bernatsky, S., Pineau, C.A., Chang, E.R., Journal of Rheumatology, 2006

Factors associated with first thrombosis in patients presenting with obstetric antiphospholipid syndrome (APS) in the APS Alliance for Clinical Trials and International Networking Clinical Database and Repository: a retrospective study, Levy, R.A., Erkan, D., Rosa, R., Nascimento, I.S., Willis, R., Atsumi, T., Knight, J.S., Cervera, R., Rodriguez, E., Petri, M., Fortin, P.R., Belmont, H.M., Andreoli, L., Branch, D.W., Cohen, H., Ugarte, A., Meroni, P.L., Ji, L., Pengo, V., Banzato, A., Tektonidou, M., Barbhaiya, M., Andrade, D., Sciascia, S., de Jesús, G.R., BJOG: An International Journal of Obstetrics and Gynaecology, 2019, 10.1111/1471-0528.15469

Rheumatoid arthritis prevalence in Quebec, Joseph, L., Feldman, D.E., Bergeron, L., Belisle, P., Chetaille, A.L., Jean, S., Bessette, L., Fortin, P.R., Boire, G., Pineau, C.A., Hudson, M., Dekis, A., Bernatsky, S., BMC Research Notes, 2014, 10.1186/1756-0500-7-937

Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus, Farewell, V., Thompson, K., Douglas, J., Zoma, A., Ramos-Casals, M., Kalunian, K., Aranow, C., Sturfelt, G., Nived, O., Van Vollenhoven, R., Ramsey-Goldman, R., Dooley, M.A., Manzi, S., Petri, M., Khamashta, M., Steinsson, K., Bruce, I.N., Ginzler, E., Merrill, J.T., Romero-Diaz, J., Sanchez-Guerrero, J., Fortin, P.R., Gladman, D.D., Alarcón, G.S., Rahman, A., Isenberg, D., Bernatsky, S., Clarke, A., Wallace, D.J., Gordon, C., Bae, S.C., Su, L., Urowitz, M.B., Hanly, J.G., Annals of the Rheumatic Diseases, 2010, 10.1136/ard.2008.106351

Anti-C1q antibodies in systemic lupus erythematosus, Petri, M., Magder, L.S., McGwin, G., Weisman, M.H., Brey, R., Pham, N., Hameed, S., Sigler, L., Franks, A.G., Steinsson, K., Rahman, A., Kamen, D.L., Inanc, M., Fessler, B.J., Lim, S.S., Callen, J.P., Jorizzo, J.L., Peschken, C., Stoll, T., Ginzler, E., Van Vollenhoven, R.F., Dooley, M.A., Maddison, P., Buyon, J.P., Jacobsen, S., Khamashta, M.A., Ruiz-Irastorza, G., Bernatsky, S., Zoma, A., Werth, V.P., Costner, M.I., Kalunian, K.C., Gladman, D.D., Urowitz, M.B., Manzi, S., Aranow, C.B., Clarke, A.E., Sanchez-Guerrero, J., Hanly, J.G., Bae, S.-C., Ramsey-Goldman, R., Wallace, D.J., Isenberg, D.A., Bruce, I.N., Fortin, P.R., Merrill, J.T., Gordon, C., Alarcón, G.S., Fang, H., Nived, O., Sturfelt, G., Truedsson, L., Orbai, A.-M., Lupus, 2015, 10.1177/0961203314547791

Identification and characterization of an Xp22.33;Yp11.2 translocation causing a triplication of several genes of the pseudoautosomal region 1 in an XX male patient with severe systemic lupus erythematosus, Busque, L., Silverman, E., Perreault, C., Bolduc, V., Gingras, M., Belisle, C., Provost, S., Fortin, P.R., Hébert, J., Schneider, R., Chagnon, P., Arthritis and Rheumatism, 2006, 10.1002/art.21733

Early medication use in new-onset rheumatoid arthritis may delay joint replacement: Results of a large population-based study, Bernatsky, S., Edworthy, S., Barnabe, C., Peschken, C., Maksymowych, W., Feldman, D., Hanly, J.G., Widdifield, J., Bombardier, C., Bessette, L., Fortin, P.R., Boire, G., Wang, Y., Lacaille, D., Beauchamp, M.-E., Abrahamowicz, M., Moura, C.S., Arthritis Research and Therapy, 2015, 10.1186/s13075-015-0713-3

Reduced proportions of natural killer T cells are present in the relatives of lupus patients and are associated with autoimmunity, Fortin, P.R., Barr, S., Albert, L., Inman, R., Carette, S., Hitchon, C., Clarke, A., Rich., E., Bernatsky, S., Urowitz, M., Boire, G., Peschken, C., Hanly, J.G., Smith, C.D., Pineau, C.A., Pope, J., Gladman, D., Greenwood, C.M.T., Paterson, A.D., Hudson, T.J., Cooper, G.S., Claudio, J.O., Roslin, N., McKenzie, T., Lim, S., Cai, Y.-C., Wither, J., Arthritis Research and Therapy, 2008, 10.1186/ar2505

IgG-aggregates rapidly upregulate FcgRI expression at the surface of human neutrophils in a FcgRII-dependent fashion: A crucial role for FcgRI in the generation of reactive oxygen species, Pouliot, M., Boilard, E., Fortin, P.R., Laflamme, C., Huot, S., FASEB Journal, 2020, 10.1096/fj.202001085R

The Impact of Pain and Itch on Functioning and Health-Related Quality of Life in Systemic Sclerosis: An Exploratory Study, Larché, M., Fortin, P.R., Smith, D., Gyger, G., Thorne, C., Grodzicky, T., Ligier, S., Mathieu, J.-P., Sutton, E., Masseto, A., Kaminska, E., Docherty, P., Khalidi, N., Jones, N., Robinson, D., Markland, J., Pope, J., Nielson, W.R., Baron, M., Hudson, M., Racine, M., Journal of Pain and Symptom Management, 2016, 10.1016/j.jpainsymman.2015.12.314

Clinical manifestations and coronary artery disease risk factors at diagnosis of systemic lupus erythematosus: Data from an international inception cohort, Buyon, J., Stoll, T., Kalunian, K., Aranow, C., Van Vollenhoven, R., Font, J., Maddison, P., Nived, O., Sturfelt, G., Zoma, A., Ramsey-Goldman, R., Khamashta, M., Manzi, S., Bruce, I., Dooley, M.A., Petri, M., Steinsson, K., Alarcon, G., Merrill, J., Ginzler, E., Isenberg, D., Wallace, D., Hanly, J., Gordon, C., Bernatsky, S., Clarke, A., Bae, S., Sanchez-Guerrero, J., Fortin, P., Ibañez, D., Gladman, D., Urowitz, M.B., Lupus, 2007, 10.1177/0961203307081113

Measuring relevant change: an emerging challenge in rheumatologic clinical trials, Katz, J.N., Stucki, G., Fortin, P.R., Arthritis & Rheumatism, 1995, 10.1002/art.1780380802

The relationship between health status, social support and satisfaction with medical care among patients with systemic lupus erythematosus, Esdaile, J.M., Danoff, D.S., Fortin, P.R., Senecal, J.-L., Dobkin, P.L., Clarke, A.E., Da Costa, D., International Journal for Quality in Health Care, 1999, 10.1093/intqhc/11.3.201

A subset of rheumatoid factors crossreacts with cardiolipin in patients positive for IgM rheumatoid factor and anticardiolipin antibodies [4], Rauch, J., Newkirk, M.M., Subang, R., Fortin, P.R., Galperin, I., Journal of Rheumatology, 2000

The Purinergic Receptor P2X4 Promotes Th17 Activation and the Development of Arthritis, Fawzi Aoudjit, Jean Sévigny, Paul R. Fortin, Mabrouka Salem, Amna Abderrazak, Chenqi Zhao, Chakib Hamoudi, The Journal of Immunology, 2022, 10.4049/jimmunol.2100550

The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index for systemic lupus erythematosus international comparison, Sturfelt, G., Snaith, M., Nived, O., Petri, M., Isenberg, D.A., Hanly, J.G., Gordon, C., Ginzler, E., Fortin, P., Bacon, P., Urowitz, M.B., Goldsmith, C.H., Gladman, D.D., Journal of Rheumatology, 2000

The Canadian Rheumatology Association/Spondyloarthritis Research Consortium of Canada treatment recommendations for the management of spondyloarthritis: A National Multidisciplinary Stakeholder Project, Inman, R., Zummer, M., Thomson, G., Starr, M., Shojania, K., Shanner, L., Savage, L., Russell, A.S., Olszynski, W.P., Mulholland, K., Mosher, D., Klinkhoff, A.V., Fortin, P., Karsh, J., Dimond, S., Choquette, D., Bykerk, V., Boonen, A., Rahman, P., Gladman, D., Maksymowych, W.P., Journal of Rheumatology, 2007

Validation of the Spanish, Portuguese and French versions of the Lupus Damage Index questionnaire: Data from North and South America, Spain and Portugal, Alarcón, G.S., Wolfe, F., Costenbader, K.H., Karlson, E.W., Liu, J.M., Gonzalez, E., Navarro, I., Roldán, J., Gentiletti, S.B., Segami, M.I., Acevedo, E.M., Weisman, M., Esteva-Spinetti, M.H., Portela, M., Santos, M.J., Calvo-Alén, J., Fortin, P.R., Vilá, L.M., Durán-Barragán, S., Manni, J.A., Silvariño, R., De La Torre, I.G., Molina, J.F., Ramirez, L.A., Burgos, P.I., Neira, O., Catoggio, L.J., Velozo, E., Souza, A.W.S., Saurit, V., Onetti, L., Marques, C.D., Scherbarth, H., Berbotto, G.A., Duarte, A., Marcos, J.C., García, M.A., Clarke, A., Bernatsky, S., Shinjo, S.K., Borba, E.F., Bonfa, E., Iglesias-Gamarra, A., Romero-Díaz, J., Sánchez-Guerrero, J., Pons-Estel, B.A., Lupus, 2009, 10.1177/0961203309105590

Timing of total joint replacement affects clinical outcomes among patients with osteoarthritis of the hip or knee, Katz, J.N., Fossel, A.H., Sledge, C., Tanzer, M., Mahomed, N., Phillips, C.B., Ferland, D., Liang, M.H., Bélisle, P., Joseph, L., St-Pierre, Y., Clarke, A.E., Penrod, J.R., Fortin, P.R., Arthritis and Rheumatism, 2002, 10.1002/art.10631

International consensus for a definition of disease flare in lupus, Merrill, J.T., Werth, V.P., Von Feldt, J.M., Urowitz, M., Strand, V., Sontheimer, R.D., Sánchez-Guerrero, J., Sammaritano, L., Petri, M., Kalunian, K.C., Isenberg, D.A., Hahn, B., Grossman, J., Gordon, C., Ginzler, E., Gilkeson, G., Franks, A.G., Fortin, P.R., Fiorentino, D., Filocamo, G., Dooley, M.A., Cronin, M.E., Costner, M.I., Buyon, J.P., Brunetta, P., Brey, R.L., Belmont, H.M., Alarcón, G.S., Hanrahan, L.M., Ruperto, N., Lupus, 2011, 10.1177/0961203310388445

Autoantibodies in systemic lupus erythematosus target mitochondrial RNA, Boilard, E., Fortin, P.R., Rauch, J., Rollet-Labelle, E., Benk-Fortin, H., Loignon, R.-C., Julien, A.-S., Allaeys, I., Marcoux, G., Becker, Y., Frontiers in Immunology, 2019, 10.3389/fimmu.2019.01026

Recruitment strategies in superiority trials in SLE: Lessons from the study of methotrexate in lupus erythematosus (SMILE), Fortin, P.R., Ferland, D., Lupus, 1999, 10.1191/096120399680411371

Transancestral mapping and genetic load in systemic lupus erythematosus, Vyse, T.J., Gaffney, P.M., Graham, R.R., Wakeland, E.K., Harley, J.B., Kimberly, R.P., Alarcón-Riquelme, M.E., Silverman, E.D., Behrens, T.W., Schanberg, L.E., Tsao, B.P., Sivils, K.L., Jacob, C.O., Criswell, L.A., Rönnblom, L., Syvänen, A.-C., Gregersen, P.K., Rioux, J.D., Oksenberg, J.R., Bhangale, T., Wither, J.E., Weisman, M.H., Wallace, D.J., Vilá, L.M., Vasconcelos, C., Tusié-Luna, T., Truedsson, L., Toloza, S.M.A., Thompson, S.D., Svenungsson, E., Sjöwall, C., Seldin, M.F., Scorza, R., Scherbarth, H.R., Aguilar-Salinas, C.A., Sabio, J.M., Russell, L.P., Reveille, J.D., Ramsey-Goldman, R., Pope, J., Raj, P., Pons-Estel, B.A., Pineau, C.A., Petri, M., Ortego-Centeno, N., Orozco, L., Niewold, T.B., Nath, S.K., Moctezuma, J.F., Miranda, P., Merrill, J.T., McWilliams, D.R., McCune, J.M., Martín, J., Maradiaga-Ceceną, M.A., Li, Q.-Z., Lauwerys, B.R., Laustrup, H., Kovács, L., Kottyan, L.C., Kaufman, K.M., Karp, D.R., Kamen, D.L., Kallenberg, C.G.M., James, J.A., Huggins, J.L., Guthridge, J.M., Gunnarsson, I., Gladman, D.D., Gilkeson, G.S., De La Torre, I.G., Garcýá, M.A., Frostegård, J., Freedman, B.I., Fortin, P.R., Esquivel-Valerio, J.A., Endreffy, E., Edberg, J.C., Doria, A., De La RúaFigueroa, I., Da Silva, B.M., D'Alfonso, S., Dahlqvist, S.R., Cucho-Venegas, J.M., Cervera, R., Catoggio, L., Cardiel, M.H., Brunner, H.I., Brown, E.E., Bijl, M., Berbotto, G.A., Bengtsson, A.A., Baca, V., Babini, A.M., Alarcón, G.S., Acevedo-Vásquez, E.M., Almlöf, J.C., Sandling, J.K., Morris, D.L., Croker, J.A., Ramos, P.S., Howard, T.D., Marion, M.C., Comeau, M.E., Kelly, J.A., Graham, D.S.C., Ainsworth, H.C., Langefeld, C.D., Nature Communications, 2017, 10.1038/ncomms16021

Can health utility measures be used in lupus research? A comparative validation and reliability study of 4 utility indices, Fortin, P.R., Neville, C., Bélisle, P., Joseph, L., Danoff, D.S., Clarke, A.E., Moore, A.D., Journal of Rheumatology, 1999

The 1000 Canadian faces of lupus: Determinants of disease outcome in a large multiethnic cohort, Huber, A., Ramsey, S., Berkson, L., Baron, M., Scuccimarri, R., Duffy, K., Campillo, S., Chedéville, G., Petty, R., Tucker, L., Hitchon, C., Inman, R.D., Carette, S., Albert, L., Cooper, G.S., Hudson, M., Bernatsky, S., Clarke, A., Zummer, M., Urowitz, M., Gladman, D.D., Arbillaga, H.O., Smith, C.D., Pineau, C., Fortin, P.R., Pope, J.E., Silverman, E., Katz, S.J., Peschken, C.A., Journal of Rheumatology, 2009, 10.3899/jrheum.080912

Assessment of the educational impact of an information leaflet on the knowledge of complications in systemic sclerosis, Michou, L., Fortin, P.R., Bessette, L., Brown, J.P., Beaudoin, C., Ikic, A., Joint Bone Spine, 2015, 10.1016/j.jbspin.2014.12.005

Neuropsychiatric Lupus: The Prevalence and Autoantibody Associations Depend on the Definition: Results from the 1000 Faces of Lupus Cohort, Peschken, C., Tucker, L., Hudson, M., Zummer, M., Urowitz, M., Gladman, D., Arbillaga, H., Smith, C.D., Pineau, C., Fortin, P.R., Silverman, E., Pope, J.E., Borowoy, A.M., Seminars in Arthritis and Rheumatism, 2012, 10.1016/j.semarthrit.2012.03.011

A discrete cluster of urinary biomarkers discriminates between active systemic lupus erythematosus patients with and without glomerulonephritis, Wither, J., Boutros, P.C., Fortin, P.R., Avila-Casado, C., Scholey, J., Bonilla, D., Reich, H., Noamani, B., Morrison, S., Prokopec, S.D., Landolt-Marticorena, C., Arthritis Research and Therapy, 2016, 10.1186/s13075-016-1120-0

The frequency and outcome of lupus nephritis: Results from an international inception cohort study, Farewell, V., Thompson, K., Theriault, C., Askanase, A., Jacobsen, S., Peschken, C.A., Maddison, P., Kamen, D.L., Kalunian, K.C., Inanc, M., Stoll, T., Sam Lim, S., Ruiz-Irastorza, G., Ramos-Casals, M., Zoma, A.A., Van Vollenhoven, R.F., Khamashta, M.A., Manzi, S., Sturfelt, G.K., Nived, O., Steinsson, K., Fessler, B.J., Aranow, C., Alarcón, G.S., Ramsey-Goldman, R., Dooley, M.A., Bruce, I.N., Petri, M., Sanchez-Guerrero, J., Gladman, D.D., Fortin, P., Ginzler, E.M., Rahman, A., Isenberg, D.A., Merrill, J.T., Wallace, D.J., Clarke, A.E., Bernatsky, S., Bae, S.-C., Gordon, C., Romero-Diaz, J., Urowitz, M.B., Su, L., O'Keeffe, A.G., Hanly, J.G., Rheumatology (United Kingdom), 2015, 10.1093/rheumatology/kev311

Mortality related to cerebrovascular disease in systemic lupus erythematosus, Hanly, J.G., Ramsey-Goldman, R., Ensworth, S., Pope, J., Sibley, J., Edworthy, S., Zummer, M., Senécal, J.-L., Barr, S.G., Fortin, P.R., Urowitz, M., Gladman, D.D., Clarke, A., Bernatsky, S., Lupus, 2006, 10.1177/0961203306073133

Accrual of Atherosclerotic Vascular Events in a Multicenter Inception Systemic Lupus Erythematosus Cohort, Stoll, T., Askanase, A., Peschken, C.A., Jacobsen, S., Kamen, D.L., Ramos-Casals, M., van Vollenhoven, R., Ỉnanç, M., Kalunian, K.C., Lim, S.S., Ruiz-Irastorza, G., Zoma, A.A., Steinsson, K., Jönsen, A., Nived, O., Ramsey-Goldman, R., Manzi, S., Dooley, M.A., Aranow, C., Khamashta, M.A., Bruce, I.N., Petri, M.A., Chatham, W.W., Alarcón, G.S., Ginzler, E., Merrill, J.T., Rahman, A., Isenberg, D.A., Wallace, D.J., Hanly, J.G., Gordon, C., Bernatsky, S., Clarke, A.E., Sanchez-Guerrero, J., Fortin, P.R., Bae, S.-C., Romero-Diaz, J., Su, J., Farewell, V., Gladman, D.D., Urowitz, M.B., Arthritis and Rheumatology, 2020, 10.1002/art.41392

Learning from discordance in patient and physician global assessments of systemic lupus erythematosus disease activity, Fortin, P.R., Ferland, D., Belisle, P., Joseph, L., Clarke, A.E., Neville, C., Journal of Rheumatology, 2000

Prediction of Damage Accrual in Systemic Lupus Erythematosus Using the Systemic Lupus International Collaborating Clinics Frailty Index, Hanly, J.G., Askanase, A., Peschken, C.A., Jacobsen, S., Kalunian, K.C., Kamen, D.L., Ramos-Casals, M., Nived, O., Jonsen, A., van Vollenhoven, R.F., Inanc, M., Lim, S.S., Ruiz-Irastorza, G., Mackay, M., Aranow, C., Zoma, A.A., Manzi, S., Ramsey-Goldman, R., Dooley, M.A., Khamashta, M.A., Petri, M., Alarcón, G.S., Rahman, A., Isenberg, D.A., Bruce, I.N., Urowitz, M.B., Gladman, D.D., Fortin, P.R., Ginzler, E.M., Merrill, J.T., Clarke, A.E., Bernatsky, S., Wallace, D.J., Sanchez-Guerrero, J., Romero-Diaz, J., Gordon, C., Bae, S.-C., Andreou, P., Rockwood, K., Kirkland, S., Legge, A., Arthritis and Rheumatology, 2020, 10.1002/art.41144

Development and Validation of the Body Concealment Scale for Scleroderma, Fortin, P., Thorne, C., LeClercq, S., Mittoo, S., Grodzicky, T., Ligier, S., Mathieu, J.-P., Docherty, P., Kaminska, E., Jones, N., Robinson, D., Khalidi, N.A., Sutton, E., Masetto, D.A., Pope, J., Thombs, B.D., Wigley, F.M., Heinberg, L., Haythornthwaite, J.A., Baron, M., Hudson, M., Steele, R.J., Körner, A., Rumsey, N., Harcourt, D., Kwakkenbos, L., Malcarne, V.L., Jewett, L.R., Arthritis Care and Research, 2016, 10.1002/acr.22819

Duration of Postvaccination Neutralizing Antibodies to SARS‐CoV‐2 and Medication Effects: Results from the Safety and Immunogenicity of COVID‐19 Vaccination in Systemic Immune‐Mediated Inflammatory Diseases Cohort Study, Sasha Bernatsky, Elizabeth Turnbull, Nadine Lalonde, Charles N. Bernstein, Daniel Pereira, Jennifer L. F. Lee, Luck Lukusa, Ines Colmegna, Maggie J. Larché, Louis Flamand, Anne‐Claude Gingras, Dawn M. E. Bowdish, Gilles Boire, Paul R. Fortin, Vinod Chandran, Carol Hitchon, Roya M. Dayam, Rami Habib, ACR Open Rheumatology, 2024, 10.1002/acr2.11697

Autoantibodies in systemic lupus erythematosus: Comparison of historical and current assessment of seropositivity, Petri, M., Weisman, M., Stoll, T., Van Vollenhoven, R.F., Steinsson, K., Dooley, M.A., Kalunian, K., Buyon, J., Magder, L.S., Zoma, A., Isenberg, D., Aranow, C., Bruce, I., Sanchez-Guerrero, J., Sturfelt, G., Nived, O., Hanly, J.G., Ginzler, E., Merrill, J.T., Bae, S.-C., Manzi, S., Bernatsky, S., Clarke, A., Maddison, P., Ramsey-Goldman, R., Alarcón, G.S., Gordon, C., Costner, M., Werth, V., Urowitz, M., Fortin, P.R., Gladman, D., Wallace, D.J., Ippolito, A., Lupus, 2011, 10.1177/0961203310385738

Prognostic factors in systemic necrotizing vasculitis of the polyarteritis nodosa group - A review of 45 cases, Esdaile, J.M., Choquette, D., Yeadon, C.A., Watters, A.K., Larson, M.G., Fortin, P.R., Journal of Rheumatology, 1995

Thinking outside the box-The associations with cutaneous involvement and autoantibody status in systemic sclerosis are not always what we expect, Fritzler, M., Larché, M., Fortin, P.R., Smith, D., Gyger, G., Thorne, C., LeClercq, S., Grodzicky, T., Ligier, S., Mathieu, J.-P., Sutton, E., Masetto, A., Kaminska, E., Docherty, P., Khalidi, N., Jones, N., Robinson, D., Markland, J., Pope, J., Fritzler, M.J., Baron, M., Wang, M., Tatibouet, S., Hudson, M., Srivastava, N., Seminars in Arthritis and Rheumatism, 2015, 10.1016/j.semarthrit.2015.04.009

Molecular markers of injury in kidney biopsy specimens of patients with lupus nephritis, Herzenberg, A.M., Scholey, J.W., Yang, S., Fortin, P.R., Wither, J., John, R., Boutros, P.C., Landolt-Marticorena, C., Reich, H.N., Journal of Molecular Diagnostics, 2011, 10.1016/j.jmoldx.2010.10.005

Factors associated with damage accrual in patients with systemic lupus erythematosus: Results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort, Urowitz, M.B., Inanc, M., Peschken, C.A., Kamen, D.L., Lim, S., Ruiz-Irastorza, G., Kalunian, K.C., Van Vollenhoven, R.F., Ramos-Casals, M., Mackay, M., Aranow, C., Nived, O., Sturfelt, G.K., Zoma, A.A., Ramsey-Goldman, R., Khamashta, M.A., Dooley, M.A., Steinsson, K., Petri, M., Fortin, P.R., Fessler, B.J., Alarcón, G.S., Merrill, J.T., Rahman, A., Isenberg, D.A., Ginzler, E.M., Bernatsky, S., Clarke, A.E., Wallace, D.J., Gordon, C., Romero-Diaz, J., Sanchez-Guerrero, J., Bae, S.-C., Gladman, D.D., Su, L., Manzi, S., Hanly, J.G., Farewell, V., O'Keeffe, A.G., Bruce, I.N., Annals of the Rheumatic Diseases, 2015, 10.1136/annrheumdis-2013-205171

Health Insurance Coverage and Clinical Outcomes in Women with Breast Cancer, Epstein, A.M., Kohler, B.A., Ayanian, J.Z., Benk, V., Fortin, P., Hamilton, V., New England Journal of Medicine, 1993, 10.1056/NEJM199312303292716

Association of smoking with cutaneous manifestations in systemic lupus erythematosus, Pineau, C.A., Belisle, P., Huber, A.M., Chédeville, G., Silverman, E., Esdaile, J., Arbillaga, H., Hudson, M., Tucker, L., Pope, J., Zummer, M., Smith, C.D., Mittoo, S., Hitchon, C., Fortin, P.R., Clarke, A.E., Joseph, L., Bernatsky, S., Peschken, C.A., Bourré-Tessier, J., Arthritis Care and Research, 2013, 10.1002/acr.21966

Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus, Gaffney, P.M., Moser, K.L., Altshuler, D., Daly, M.J., Vyse, T.J., Wong, A.K., Cunninghame Graham, D., Fortin, P.R., Rioux, J.D., Wither, J.E., Behrens, T.W., Plenge, R.M., Gates, C., Parkin, M., Guiducci, C., Burtt, N.P., Leon, J.M., Lessard, C.J., Hackett, R., Davies, L., Cotsapas, C., Graham, R.R., Nature Genetics, 2008, 10.1038/ng.200

The Presence of Multiple Prothrombotic Risk Factors Is Associated with a Higher Risk of Thrombosis in Individuals with Anticardiolipin Antibodies, Fortin, P.R., Busque, L., Kassis, J., Séguin, C., Ibrahim, R., Chang, E., Neville, C., Rauch, J., Herr, A.-L., Hudson, M., Journal of Rheumatology, 2003

Using Optimal Test Assembly Methods for Shortening Patient-Reported Outcome Measures: Development and Validation of the Cochin Hand Function Scale-6: A Scleroderma Patient-Centered Intervention Network Cohort Study, Mills, S.D., Gholizadeh, S., Fox, R.S., Pepin, M.R., Fedoruk, C., Thorne, C., Sutton, E., Steen, V., Smith, D., Schiopu, E., Robinson, D., Manning, J., Jones, N., Varga, J., Korman, B., Hinchcliff, M., Herrick, A.L., Spiera, R., Gordon, J., Wilcox, P., Dunne, J.V., Domsic, R., Gill, A., Denton, C., Chung, L., Carreira, P., Roux, S., Masetto, A., Liang, P., Fernandes, A.J.D.B., Dagenais, P., Bruns, A., Boire, G., Bissonnette, L., Arsenault, G., Ikic, A., Fortin, P., Albert, A., Wong-Rieger, D., Suarez-Almazor, M.E., Reyna, T.S.R., Portales, A., Pope, J., Marra, C., Khalidi, N., Larche, M., Kennedy, A.T., Johnson, S.R., Impens, A., Milette, K., Levis, B., Jewitt, L.R., Delisle, V.C., Gyger, G., Hudson, M., Godard, D., Frech, T., Nielsen, K., Fortune, C., Fligelstone, K., Persmann, J., El-Baalbaki, G., Leite, C., Maia, A.C., Boutron, I., Wigley, F., Riggs, R., Nielson, W.R., Assassi, S., Mayes, M.D., van den Hoogen, F., Gottesman, K., Kafaja, S., Furst, D., Steele, R.J., Jang, Y., Ells, C., Baron, M., Thombs, B.D., Welling, J., Schouffoer, A.A., Poole, J.L., van den Ende, C.H.M., Sauve, M., Malcarne, V.L., Khanna, D., Bartlett, S.J., Poiraudeau, S., Mouthon, L., Carrier, M.-E., Kwakkenbos, L., Harel, D., Levis, A.W., Arthritis Care and Research, 2016, 10.1002/acr.22893

Impact of early disease factors on metabolic syndrome in systemic lupus erythematosus: Data from an international inception cohort, Bruce, I.N., Inanc, M., Peschken, C.A., Kamen, D.L., Lim, S.S., Ruiz-Irastorza, G., Kalunian, K.C., Van Vollenhoven, R.F., Ramos-Casals, M., Mackay, M., Aranow, C., Nived, O., Sturfelt, G.K., Zoma, A.A., Ramsey-Goldman, R., Khamashta, M.A., Manzi, S., Dooley, M.A., Steinsson, K., Petri, M., Hanly, J.G., Fortin, P.R., Fessler, B.J., Alarcón, G.S., Merrill, J.T., Rahman, A., Isenberg, D.A., Ginzler, E.M., Bernatsky, S., Clarke, A.E., Wallace, D.J., Gordon, C., Romero-Diaz, J., Sanchez-Guerrero, J., Bae, S.-C., Donn, R., Lunt, M., Gladman, D.D., Urowitz, M.B., Parker, B., Annals of the Rheumatic Diseases, 2015, 10.1136/annrheumdis-2013-203933

A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis, Puechal, X., Ludivico, C., Segal, A.M., Gross, W., Choi, H.K., Soubrier, M., Ferland, D., Walsh, B., Baca, S., Sherrer, Y., McRorie, E., Nuki, G., Luqmani, R.A., Prayson, R., Kosmorsky, G., Fessler, B.J., Mandell, B.F., Scheetz, R.J., Wilke, W.S., Klashman, D., Kalunian, K., Hoffman, D.B., Bork, D., Lopez-Soto, A., Hernández-Rodríguez, J., Swanson, H., Tuggle, C., Sneller, M.C., Hunder, G.G., Schned, E., Easley, K.A., Locker, G.A., Flynn, J.A., Fortin, P., Merkel, P.A., Dickler, H., Calabrese, L.H., Cohen, P., Schousboe, J., Stone, J.H., Guillevin, L., Hellmann, D.B., Cid, M.C., Hoffman, G.S., Arthritis and Rheumatism, 2002, 10.1002/art.10262

Comparison of real world and core laboratory lupus anticoagulant results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) clinical database and repository, Cohen, H., Pengo, V., Bertolaccini, M.L., Sevim, E., Vega, J., Atsumi, T., Cervera, R., Knight, J.S., Rodriguez, E., Petri, M., Andreoli, L., Fortin, P.R., de Jesus, G., Branch, D.W., Ji, L., Aguirre, M.A., Belmont, H.M., Chighizola, C., Ugarte, A., Qi, M., Tektonidou, M., Romay-Penabad, Z., Borges Galhardo Vendramini, M., Bison, E., Krillis, S., Sciascia, S., Erkan, D., Willis, R., Andrade, D., Lane, P.J., Mackie, I.J., Efthymiou, M., Journal of Thrombosis and Haemostasis, 2019, 10.1111/jth.14596

Antiphospholipid antibodies predict imminent vascular events independently from other risk factors in a prospective cohort, Fortin, P.R., Levine, J.S., Belisle, P., Joseph, L., Solymoss, S., Kassis, J., Rauch, J., Neville, C., Thrombosis and Haemostasis, 2009, 10.1160/TH08-06-0384

The role of mitochondria in rheumatic diseases, Eric Boilard, Christian Lood, Paul R. Fortin, Bhargavi Duvvuri, Yann L. C. Becker, Nature Reviews Rheumatology, 2022, 10.1038/s41584-022-00834-z

The relationship between health related quality of life and disease activity and damage in systemic lupus erythematosus, Fortin, P.R., Mayo, N.E., Wang, C., Journal of Rheumatology, 2001

Comparison of the 2019 European Alliance of Associations for Rheumatology/American College of Rheumatology Systemic Lupus Erythematosus Classification Criteria With Two Sets of Earlier Systemic Lupus Erythematosus Classification Criteria, Laurence S. Magder, Andrew G. Franks, Jr, Kristjan Steinsson, Anisur Rahman, Diane L. Kamen, Murat Inanç, Sam Lim, Jeffery P. Callen, Joseph L. Jorizzo, Christine Peschken, Thomas Stoll, Ellen Ginzler, Ronald van Vollenhoven, Mary Anne Dooley, Jill P. Buyon, Søren Jacobsen, Munther Khamashta, Sasha Bernatsky, Asad Zoma, Victoria P. Werth, Ken Kalunian, Dafna D. Gladman, Murray Urowitz, Susan Manzi, Cynthia Aranow, Ann E. Clarke, Jorge Sanchez‐Guerrero, John G. Hanly, Sang‐Cheol Bae, Rosalind Ramsey‐Goldman, Ola Nived, Daniel Wallace, David Isenberg, Ian N. Bruce, Paul R. Fortin, Joan T. Merrill, Caroline Gordon, Graciela S. Alarcón, Daniel W. Goldman, Michelle Petri, Arthritis Care & Research, 2021, 10.1002/acr.24263

Purpura fulminans and anticardiolipin antibodies in a patient with Grave's disease, Fortin, P.R., Kassis, J., Watters, A.K., Pham, C.D., Ligier, S., Scandinavian Journal of Rheumatology, 2002, 10.1080/030097402320817112

Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus, Senécal, J.-L., Clarke, A.E., Fortin, P.R., Grover, S.A., Cé, R., Berger, R.D., Panaritis, C., Li, Y., Grodzicky, T., Abrahamowicz, M., Esdaile, J.M., Arthritis and Rheumatism, 2001, 10.1002/1529-0131(200110)44:10<2331::AID-ART395>3.0.CO;2-I

Anti-nucleosome antibodies outperform traditional biomarkers as longitudinal indicators of disease activity in systemic lupus erythematosus, Landolt-Marticorena, C., Wither, J., Boutros, P.C., Fortin, P.R., Scholey, J., Urowitz, M., Gladman, D., Reich, H., Lou, W., Morrison, S., Prokopec, S.D., Li, T., Rheumatology (Oxford, England), 2015, 10.1093/rheumatology/keu326

Lung cancer in systemic lupus erythematosus, Clarke, A.E., Ramsey-Goldman, R., Sturfeldt, G., Nived, O., Petri, M., Rahman, A., Isenberg, D., Manzi, S., Urowitz, M., Fortin, P.R., Gladman, D., Ginzler, E., Boivin, J.-F., Gordon, C., Bernatsky, S., Bin, J., Lung Cancer, 2007, 10.1016/j.lungcan.2007.01.007

Recurrent thrombosis in patients with antiphospholipid antibodies and an initial venous or arterial thromboembolic event: A systematic review and meta-analysis, Whitehead, N., Phillips, M.J., Levine, S.R., Kosinski, A.S., Haywood, N., Garcia, D., Fortin, P.R., Erkan, D., Crowther, M., Catellier, D., Meleth, S., Ortel, T.L., Journal of Thrombosis and Haemostasis, 2020, 10.1111/jth.14936

The longterm effect of early intensive treatment of seniors with rheumatoid arthritis: A comparison of 2 population-based cohort studies on time to joint replacement surgery, Bernatsky, S., Feldman, D., Hanly, J.G., Bombardier, C., Bessette, L., Fortin, P.R., Boire, G., Beauchamp, M.-E., Huang, A., Michael Paterson, J., Abrahamowicz, M., Wang, Y., Moura, C.S., Widdifield, J., Journal of Rheumatology, 2016, 10.3899/jrheum.151156

Responsiveness and sensitivity to change of SLE disease activity measures, Stucki, G., Fortin, P., Corzillius, M., Lupus, 1999, 10.1191/096120399680411416

Criteria for steroid-sparing ability of interventions in systemic lupus erythematosus: Report of a consensus meeting, Strand, V., St.Clair, E.W., Smolen, J., Schur, P., Roberts Jr., N., Phillips, C., Petri, M., Mosca, M., Moore, A., Mikdashi, J., Meyrier, A., McCune, J., Manzi, S., Lockshin, M., Koike, T., Khamashta, M., Kalden, J., Johnson, K., Illei, G., Gladman, D., Fischer-Betz, R., Esdaile, J.M., De Pablo, P., Crofford, L., Chehab, G., Buyon, J., Bombardieri, S., Bischoff-Ferrari, H., Benito-Garcia, E., Balow, J., Alarcón, G.S., Abrahamowicz, M., Schneider, M., Fortin, P., Liang, M.H., Arthritis and Rheumatism, 2004, 10.1002/art.20599

Posterior Reversible Encephalopathy Syndrome: An Emerging Disease Manifestation in Systemic Lupus Erythematosus, Fortin, P.R., Urowitz, M.B., Gladman, D.D., Leclerc, R., Barber, C.E., Seminars in Arthritis and Rheumatism, 2011, 10.1016/j.semarthrit.2011.07.001

Erratum: Incorrect values for intractable and cluster headaches at enrollment shown in figure 1 and incorrect prevalence of headache at ten years in text of the article by hanly et al (Arthritis and Rheumatology (2013)), Farewell, V., Thompson, K., Theriault, C., Jacobsen, S., Peschken, C.A., Kamen, D.L., Inanc, M., Lim, S.S., Kalunian, K.C., Ruiz-Irastorza, G., Mackay, M., Aranow, C., Ramos-Casals, M., Van Vollenhoven, R.F., Zoma, A.A., Nived, O., Sturfelt, G.K., Manzi, S., Ramsey-Goldman, R., Khamashta, M.A., Steinsson, K., Dooley, M.A., Bruce, I.N., Alarcõn, G.S., Fessler, B.J., Gladman, D.D., Fortin, P.R., Petri, M., Merrill, J.T., Rahman, A., Isenberg, D.A., Ginzler, E.M., Wallace, D.J., Bernatsky, S., Clarke, A.E., Romero-Diaz, J., Sanchez-Guerrero, J., Bae, S.-C., Gordon, C., O'Keeffe, A.G., Urowitz, M.B., Hanly, J.G., Arthritis and Rheumatology, 2014, 10.1002/art.38707

A new antibody in rheumatoid arthritis targeting glycated IgG: IgM anti-IgG-AGE, Newkirk, M.M., Fortin, P.R., Ligier, S., British Journal of Rheumatology, 1998

Influence of Education on Disease Activity and Damage in Systemic Lupus Erythematosus: Data From the 1000 Canadian Faces of Lupus, Pope, J.E., Nevskaya, T., Fortin, P.R., Hitchon, C., Hudson, M., Bernatsky, S., Zummer, M., Arbillaga, H., Smith, C.D., Pineau, C., Silverman, E., Peschken, C.A., Wong-Pak, A., George, A., Arthritis Care and Research, 2017, 10.1002/acr.22922

Chest radiographs as a screening test for diffuse idiopathic skeletal hyperostosis, Esdaile, J.M., Fortin, P.R., Shiroky, J.B., Fitzcharles, M.-A., Watts, C.S., Dussault, R., Kaplan, P., Joseph, L., Hill, R.O., Mata, S., Journal of Rheumatology, 1993

Use of combined hormonal contraceptives among women with systemic lupus erythematosus with and without medical contraindications to oestrogen, Vinet, E., Costedoat-Chalumeau, N., Bruce, I.N., Sanchez-Guerrero, J., Askanase, A., Jacobsen, Sø., Peschken, C.A., Kamen, D.L., Inanc, M., Kalunian, K.C., Lim, S., Ruiz-Irastorza, G., Ramos-Casals, M., Van Vollenhoven, R.F., Zoma, A.A., Jönsen, A., Nived, O., Manzi, S., Alarcón, G., MacKay, M., Aranow, C., Khamashta, M.A., Ramsey-Goldman, R., Steinsson, K., Gladman, D.D., Fortin, P., Dooley, M.A., Petri, M., Ginzler, E.M., Rahman, A., Isenberg, D.A., Buyon, J., Merrill, J.T., Wallace, D.J., Bae, S.-C., Gordon, C., Romero-Diaz, J., Clarke, A.E., Urowitz, M.B., Hanly, J.G., St-Pierre, Y., Pineau, C.A., Bernatsky, S., Mendel, A., Rheumatology (United Kingdom), 2019, 10.1093/rheumatology/kez014

Evaluating the Properties of a Frailty Index and Its Association With Mortality Risk Among Patients With Systemic Lupus Erythematosus, Hanly, J.G., Askanase, A., Peschken, C.A., Jacobsen, S., Kalunian, K., Kamen, D.L., Ramos-Casals, M., Nived, O., Jonsen, A., van Vollenhoven, R.F., Inanc, M., Lim, S.S., Ruiz-Irastorza, G., Mackay, M., Aranow, C., Zoma, A.A., Steinsson, K., Manzi, S., Ramsey-Goldman, R., Dooley, M.A., Khamashta, M.A., Petri, M., Alarcón, G.S., Rahman, A., Isenberg, D., Bruce, I.N., Urowitz, M.B., Gladman, D.D., Fortin, P., Ginzler, E.M., Merrill, J., Clarke, A.E., Bernatsky, S., Wallace, D.J., Sanchez-Guerrero, J., Romero-Diaz, J., Gordon, C., Bae, S.-C., Andreou, P., Rockwood, K., Kirkland, S., Legge, A., Arthritis and Rheumatology, 2019, 10.1002/art.40859

Distinct subtypes of microparticle-containing immune complexes are associated with disease activity, damage, and carotid intima-media thickness in systemic lupus erythematosus, Boilard, E., Laflamme, N., Simonyan, D., Eder, L., Aghdassi, E., Bissonnette, V., Cloutier, N., Fortin, P.R., Journal of Rheumatology, 2016, 10.3899/jrheum.160050

Randomized feasibility trial of the Scleroderma patient-centered intervention network hand exercise program (SPIN-HAND): Study protocol, Turner, K., Pepin, M.R., Mills, S.D., Levis, B., Jewett, L.R., Gholizadeh, S., Fox, R.S., Cumin, J., Wilcox, P., Varga, J., Thorne, C., Terrier, B., Sutton, E., Steen, V., Spiera, R., Sobanski, V., Smith, D., Smets, P., Roux, S., Rodriguez, E., Robinson, D., Rivière, S., Régent, A., Paule, R., Mekinian, A., Maurier, F., Masetto, A., Martin, T., Martin, M., Manning, J., Luna, D., London, J., Liang, P., Launay, D., Lambert, M., Korman, B., Khalidi, N., Kafaja, S., Fernandes, A.J.B., Jones, N., Ikic, A., Hinchcliff, M., Hij, A., Herrick, A.L., Hatron, P.-Y., Hachulla, E., Gyger, G., Grange, C., Granel-Rey, B., Gordon, J., Gill, A., Fortin, P.R., Farge-Bancel, D., Fare, R., Dunne, J.V., Domsic, R., Denton, C., Dagenais, P., Cohen, P., Chung, L., Chaigne, B., Casadevall, M., Carreira, P., Boire, G., Bruns, A., Bissonnette, L., Berthier, S., Benzida, I., Benmostefa, N., Arsenault, G., André, M., Albert, A., Agard, C., Wong-Rieger, D., Suarez-Almazor, M.E., Steele, R.J., Reyna, T.S.R., Portales, A., Pope, J., Nielsen, K., Marra, C., Leite, C., Larche, M., Körner, A., Kennedy, A.T., Johnson, S.R., Jang, Y., Impens, A., Harel, D., Godard, D., Frech, T., Fortune, C., Fligelstone, K., Ells, C., El-Baalbaki, G., Maia, A.C., Assassi, S., Wigley, F., Riggs, R., Nielson, W.R., Malcarne, V., Mayes, M.D., van den Hoogen, F., Gottesman, K., Furst, D., Bartlett, S.J., Baron, M., Mouthon, L., Hudson, M., Thombs, B.D., Schouffoer, A.A., van den Ende, C., Sauve, M., Welling, J., Boutron, I., Kwakkenbos, L., Carrier, M.-E., Journal of Scleroderma and Related Disorders, 2018, 10.5301/jsrd.5000263

Measuring clinically important changes with patient-oriented questionnaires., Daltroy, L., Fortin, P.R., Stucki, G., Lew, R.A., Liang, M.H., Medical care, 2002, 10.1097/00005650-200204001-00008

The rate and pattern of organ damage in late onset systemic lupus erythematosus, Sturfelt, G., Ramsey-Goldman, R., Petri, M., Nived, O., Manzi, S., Hanly, J., Gladman, D., Ginzler, E., Fortin, P., Buyon, J., Barr, S., Bae, S.-C., Aranow, C., Isenberg, D., Farewell, V., Maddison, P., Journal of Rheumatology, 2002

FcgRIIA expression accelerates nephritis and increases platelet activation in systemic lupus erythematosus, Boilard, E., Fortin, P.R., Lacroix, S., Rondina, M.T., Machlus, K.R., McKenzie, S.E., Droit, A., Lood, C., Rauch, J., Patey, N., Lévesque, T., Zufferey, A., Laroche, A., Salem, D., Rowley, J.W., Campbell, R.A., Cloutier, N., Mailhot, B., Tessandier, N., Allaeys, I., Melki, I., Blood, 2020, 10.1182/blood.2020004974

Thrombovascular events affect quality of life in patients with systemic lupus erythematosus, Fortin, P.R., Urowitz, M.B., Gladman, D.D., Yeo, E., Aghdassi, E., Su, J., Peeva, V., Balitsky, A.K., Journal of Rheumatology, 2011, 10.3899/jrheum.101054

Factors associated with fears due to COVID-19: A scleroderma patient-centered intervention network (SPIN) COVID-19 cohort study, Ellis, K., Duchek, D., Bustamante, L., Hebblethwaite, S., El-Baalbaki, G., Dyas, L., Culos-Reed, N., Turner, K.A., Rice, D.B., Østbø, N., Nordlund, J., Ayala, M.C., Wilcox, P., Thorne, C., Sutton, E., Steen, V., Sobanski, V., Roux, S., Rodriguez, E., Robinson, D., Rivière, S., Régent, A., Proudman, S., Olagne, L., Nikpour, M., Melchor, S., Mekinian, A., Martin, M., Marie, I., Manning, J., Launay, D., Khalidi, N., Kafaja, S., Fernandes, A.J.D.B., Jones, N., Hoa, S., Herrick, A.L., Hatron, P.-Y., Granel-Rey, B., Gordon, J., Fortin, P.R., Farge-Bancel, D., Dunogue, B., Dunne, J.V., Domsic, R., Denton, C., Correia, C., Chung, L., Chaigne, B., Carreira, P., Bruns, A., Bissonnette, L., Berthier, S., Bernstein, E.J., Albert, A., Agard, C., Suarez-Almazor, M.E., Schouffoer, A.A., Reyna, T.S.R., Rannou, F., Pope, J., Nguyen, C., Larche, M., Johnson, S.R., Hudson, M., Hinchcliff, M., Harel, D., Frech, T., van den Ende, C., Ells, C., Assassi, S., Riggs, R., Nielson, W.R., Mayes, M.D., Malcarne, V., Baron, M., Pérez, E., Leite, C., Gottesman, K., Fligelstone, K., Welling, J., Sauvé, M., Richard, M., Lewis, N., Guillot, G., Gietzen, A., Fortuné, C., Thombs, B.D., Benedetti, A., Varga, J., Mouthon, L., Bartlett, S.J., Patten, S., Negeri, Z., Carboni-Jiménez, A., Tao, L., Bourgeault, A., Harb, S., Gagarine, M., Carrier, M.-E., Henry, R.S., Kwakkenbos, L., Wu, Y., Journal of Psychosomatic Research, 2021, 10.1016/j.jpsychores.2020.110314

Clinical associations of the metabolic syndrome in systemic lupus erythematosus: Data from an international inception cohort, Bruce, I.N., Inanc, M., Peschken, C.A., Kamen, D.L., Lim, S., Ruiz-Irastorza, G., Kalunian, K.C., Van Vollenhoven, R.F., Ramos-Casals, M., MacKay, M., Aranow, C., Nived, O., Sturfelt, G.K., Zoma, A.A., Ramsey-Goldman, R., Khamashta, M.A., Manzi, S., Dooley, M.-A., Steinsson, K., Petri, M., Hanly, J.G., Fortin, P.R., Fessler, B.J., Alarcón, G.S., Merrill, J.T., Rahman, A., Isenberg, D.A., Ginzler, E.M., Bernatsky, S., Clarke, A.E., Wallace, D.J., Gordon, C., Romero-Diaz, J., Sanchez-Guerrero, J., Bae, S.-C., Lunt, M., Gladman, D.D., Urowitz, M.B., Parker, B., Annals of the Rheumatic Diseases, 2013, 10.1136/annrheumdis-2012-202106

Factor V Leiden, prothrombin gene mutation, and thrombosis risk in patients with antiphospholipid antibodies, Hanly, J.G., Docherty, P., Senécal, J.-L., Fortin, I., Rauch, J., Fortin, P.R., Greer, W.L., Koren, S., Chopra, N., Journal of Rheumatology, 2002

The comparison of real world and core laboratory antiphospholipid antibody ELISA results from antiphospholipid syndrome alliance for clinical trials & international networking (APS ACTION) clinical database and repository analysis, Bertolaccini, M.L., Mackie, I., Efthymiou, M., Cohen, H., Erkan, D., Banzato, A., Rosa, R., Nascimento, I., Atsumi, T., Rodriguez-Pinto, I., Rodriguez, E., Petri, M., Fortin, P.R., Nalli, C., Levy, R.A., Branch, D.W., Chighizola, C., Ugarte, A., Tektonidou, M.G., Andrade, D., Krilis, S., Pengo, V., Willis, R., Sciascia, S., Thrombosis Research, 2019, 10.1016/j.thromres.2019.01.010

Burden of autoantibodies and association with disease activity and damage in systemic lupus erythematosus, Urowitz, M.B., Fortin, P.R., Ibañez, D., Toloza, S.M., Tulloch-Reid, D., Gladman, D.D., Touma, Z., Clinical and Experimental Rheumatology, 2010

The use of alternative medical therapies in patients with systemic lupus erythematosus, Clarke, A.E., Esdaile, J.M., Grodzicky, T., Choquette, D., Goulet, J.R., Sutcliffe, N., Fortin, P.R., Penrod, J., Joseph, L., Pierre, Y.S.T., Senécal, J.-L., Gordon, C., Isenberg, D.A., Manzi, S., Petri, M.A., Moore, A.D., Arthritis and Rheumatism, 2000, 10.1002/1529-0131(200006)43:6<1410::AID-ANR27>3.0.CO;2-U

Glucocorticoid use and factors associated with variability in this use in the Systemic Lupus International Collaborating Clinics Inception Cohort, Bruce, I.N., Sanchez-Guerrero, J., Askanase, A., Jacobsen, S., Peschken, C.A., Kamen, D.L., Inanc, M., Kalunian, K.C., Lim, S.S., Ruiz-Irastorza, G., Ramos-Casals, M., van Vollenhoven, R.F., Zoma, A.A., Jönsen, A., Nived, O., Manzi, S., Alarcón, G.S., Mackay, M., Aranow, C., Khamashta, M.A., Ramsey-Goldman, R., Steinsson, K., Gladman, D.D., Fortin, P., Dooley, M.A., Petri, M., Ginzler, E.M., Rahman, A., Isenberg, D.A., Buyon, J., Merrill, J.T., Wallace, D.J., Bernatsky, S., Bae, S.-C., Gordon, C., Romero-Diaz, J., Clarke, A.E., Urowitz, M.B., Hanly, J.G., Lunt, M., Parker, B., Little, J., Rheumatology (United Kingdom), 2018, 10.1093/rheumatology/kex444

Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus, Magder, L.S., McGwin Jr., G., Weisman, M.H., Brey, R., Pham, N., Fang, H., Hameed, S., Sigler, L., Franks Jr., A.G., Steinsson, K., Rahman, A., Kamen, D.L., Inanc, M., Fessler, B.J., Lim, S.S., Callen, J.P., Jorizzo, J.L., Peschken, C., Stoll, T., Ginzler, E., Van Vollenhoven, R.F., Dooley, M.A., Maddison, P., Buyon, J.P., Jacobsen, S., Khamashta, M.A., Ruiz-Irastorza, G., Bernatsky, S., Zoma, A., Werth, V.P., Costner, M., Kalunian, K., Gladman, D., Urowitz, M., Manzi, S., Aranow, C., Clarke, A., Sánchez-Guerrero, J., Hanly, J.G., Bae, S.-C., Ramsey-Goldman, R., Sturfelt, G., Nived, O., Wallace, D.J., Isenberg, D., Bruce, I.N., Fortin, P.R., Merrill, J.T., Gordon, C., Alarcõn, G.S., Orbai, A.-M., Petri, M., Arthritis and Rheumatism, 2012, 10.1002/art.34473

Should tetracycline treatment be used more extensively for rheumatoid arthritis? Metaanalysis demonstrates clinical benefit with reduction in disease activity, Inman, R.D., Pacheco-Tena, C., Fortin, P.R., Stone, M., Journal of Rheumatology, 2003

The association of sociodemographic and objectively-assessed disease variables with fatigue in systemic sclerosis: an analysis of 785 Canadian Scleroderma Research Group Registry patients, Fritzler, M., Fortin, P.R., Thorne, C., Smith, D., Rodriguez-Reyna, T.S., Robinson, D., Sutton, E., Masetto, A., Khalidi, N., Larché, M., Pope, J., Gyger, G., Hudson, M., and the Canadian Scleroderma Research Group, Thombs, B.D., Baron, M., Hudson, M., Kwakkenbos, L., Levis, B., Clinical Rheumatology, 2017, 10.1007/s10067-016-3501-9

Abetimus sodium for renal flare in systemic lupus erythematosus: Results of a randomized, controlled phase III trial, Zummer, M., Williams, G.W., Weaver, C., Vilardell-Tarres, M., Vijayan, A., Van Vollenhoven, R., Torres, A., Tindall, E.A., Sturfelt, G., Surbeck, W., Stevens, M.P., Spira, M., Spinowitz, B., Smith, D., Sisay, M., Sibilia, J., Sherrer, Y., Shergy, W.J., Schneider, M., Scarpa, N., Rothfield, N., Roth, A., Ramsey-Goldman, R., Quinet, R.J., Pogue, B.C., Petri, M., Neuwelt, C.M., Moritz, C., Moreland, L.W., Merrill, J.T., Mease, P.J., McKay, J., Martin, K., Manzi, S., Manion, C.V., Loveless, J., Lourie, S.H., Liebling, M., Kurtzman, N.A., Krishnan, M., Kovacs, C., Kivitz, A.J., Khamashta, M., Kenney, H.M., Katz, R., Kennedy, A., Kaplan, S., Kaplan, M.J., Kammer, G.M., Kalden, J.R., Jakes, J., Jaffer, A., Hura, C.E., Howard, P., Hiepe, F., Grossman, J., Granda, J., Gorevic, P., Ginzler, E., Gilkeson, G.S., Geppert, T., Fortin, P., Fondal, M., Espinoza, L.R., Ensworth, S., Emery, P., El-Shahawy, M.A., Edwards, M., Donohue, J., Desir, D., DeHoratius, R., Cush, J.J., Cronin, M.E., Condemi, J.J., Buyon, J., Brodeur, J., Bombardieri, S., Boling, E.P., Belmont, H.M., Becker, M.A., Ballou, S., Aranow, C., Appel, G.B., Aelion, J., Abeles, M., Linnik, M.D., Joh, T., Wallace, D.J., Furie, R.A., Tumlin, J.A., Cardiel, M.H., Arthritis and Rheumatism, 2008, 10.1002/art.23673

Vasculitis and malignancy, Fortin, P.R., Inflammatory Diseases of Blood Vessels, 2016

Medication use in systemic lupus erythematosus, Clarke, A.E., Arbillaga, H.O., Smith, C.D., Zummer, M., Hudson, M., Pope, J.E., Gladman, D.D., Urowitz, M.B., Pineau, C.A., Fortin, P.R., Peschken, C., Bernatsky, S., Journal of Rheumatology, 2011, 10.3899/jrheum.100414

Temporal trends in prevalence, incidence, and mortality for rheumatoid arthritis in Quebec, Canada: a population-based study, Bernatsky, S., Boire, G., Fortin, P.R., Bessette, L., Gamache, P., Hudson, M., Jean, S., Clinical Rheumatology, 2017, 10.1007/s10067-017-3796-1

Fatal pulmonary venoocclusive disease secondary to a generalized venulopathy: A new syndrome presenting with facial swelling and pericardial tamponade, Murphy, G., Mudge, G.H., Marsh, J.D., Louie, D.C., Fortin, P.R., Stern, S., Liang, M.H., Arthritis & Rheumatism, 1991, 10.1002/art.1780340217

Outcomes of total hip and knee replacement: Preoperative functional status predicts outcomes at six months after surgery, Katz, J.N., Sledge, C.B., Mahomed, N., Fossel, A.H., Bélisle, P., Partridge, A.J., Phillips, C., Ferland, D., Tanzer, M., Liang, M.H., Joseph, L., Clarke, A.E., Fortin, P.R., Arthritis and Rheumatism, 1999, 10.1002/1529-0131(199908)42:8<1722::AID-ANR22>3.0.CO;2-R

Validation of a systemic lupus activity questionnaire (SLAQ) for population studies, Fortin, P.R., Liang, M.H., Partridge, A.J., Wright, E.A., Ramsey-Goldman, R., Rivest, C., Daltroy, L.H., Karlson, E.W., Lupus, 2003, 10.1191/0961203303lu332oa

Discordance between patients and their physicians in the assessment of lupus disease activity: Relevance for clinical trials, Fortin, P.R., Neville, C., Yen, J.C., Lupus, 1999, 10.1191/096120399680411362

Systemic autoimmune rheumatic disease prevalence in Canada: Updated analyses across 7 provinces, Bernatsky, S., Bergeron, L., Badley, E.M., Bélisle, P., Smith, M., Clarke, A.E., Pineau, C.A., Svenson, L., Edworthy, S.M., Peschken, C., Jean, S., Hudson, M., Fortin, P.R., Barnabe, C., O'Donnell, S., Lix, L., Hanly, J.G., Joseph, L., Lacaille, D., Aviña-Zubieta, J.A., Broten, L., Journal of Rheumatology, 2014, 10.3899/jrheum.130667

Systemic lupus erythematosus, a disease associated with low levels of clusterin/ApoJ, an antiinflammatory protein, Fortin, P.R., Neville, C., Apostolakos, P., Newkirk, M.M., Journal of Rheumatology, 1999

The systemic lupus erythematosus tri-nation study: Absence of a link between health resource use and health outcome, Heaton, S., Rairie, J., Orsini-Dudin, M., Neville, C., Ferland, D., Trifero, M., Margonis, K., Panaritis, P., Panaritis, T., Esdaile, J.M., Grodzicky, T., Choquette, D., Goulet, J.R., Sutcliffe, N., Fortin, P.R., St Pierre, Y., Joseph, L., Penrod, J., Senécal, J.-L., Gordon, C., Isenberg, D.A., Manzi, S., Petri, M., Clarke, A.E., Rheumatology, 2004, 10.1093/rheumatology/keh229

Do lupus disease activity measures detect clinically important change?, Liang, M.H., Fraenkel, L., Du Berger, R., Neville, C., Clarke, A.E., Abrahamowicz, M., Fortin, P.R., Journal of Rheumatology, 2000

Reliability and Validity of Three Versions of the Brief Fear of Negative Evaluation Scale in Patients With Systemic Sclerosis: A Scleroderma Patient-Centered Intervention Network Cohort Study, Turner, K., Thorne, C., Sutton, E., Steen, V., Smith, D., Robinson, D., Rivière, S., Maurier, F., Martin, T., Manning, J., Jones, N., Varga, J., Herrick, A.L., Sobanski, V., Grange, C., Granel-Rey, B., Spiera, R., Fortin, P.R., Wilcox, P., Domsic, R., Gill, A., Chung, L., Rodriguez, E., Berthier, S., Hij, A., Terrier, B., Roux, S., Smets, P., Ikic, A., Agard, C., Wong-Rieger, D., Welling, J., Suarez-Almazor, M.E., Levis, B., Schouffoer, A.A., Luna, D., Portales, A., Pope, J., Marra, C., Khalidi, N., Kennedy, A.T., Johnson, S.R., Impens, A., Harel, D., Godard, D., Frech, T., Fligelstone, K., van den Ende, C., El-Baalbaki, G., Leite, C., Maia, A.C., Boutron, I., Wigley, F., Nielsen, K., Riggs, R., Nielson, W.R., Mouthon, L., Assassi, S., van den Hoogen, F., Kafaja, S., Körner, A., Jang, Y., Hudson, M., Ells, C., Bartlett, S.J., Baron, M., Malcarne, V.L., Thombs, B.D., Mayes, M.D., Gottesman, K., Furst, D.E., Assassi, S., Merz, E.L., Roesch, S.C., Jewett, L.R., Gholizadeh, S., Mills, S.D., Carrier, M.-E., Kwakkenbos, L., Fox, R.S., Arthritis Care and Research, 2018, 10.1002/acr.23532

The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes, Winer, J.B., Wallace, D.J., Waterhouse, E., Levine, S.R., Iverson, G., Hay, E.M., Harten, P., Fisk, J.D., Filley, C.M., Cornblath, W.D., Brey, R., Veilleux, M., Sanchez-Guerrero, J., Roberts, W.N., Petri, M., Moore, P.M., McCune, J., Lockshin, M.D., Lahita, R.G., West, S., Kozora, E., Hanly, J.G., Schur, P.H., Rogers, M.P., Khoshbin, S., Karlson, E.W., Glanz, B.I., Esdaile, J.M., Denburg, S., Denburg, J., Straaton, K.V., Alarcón, G.S., Isenberg, D., Gordon, C., Fortin, P.R., Lew, R.A., Bae, S.-C., Corzillius, M., Liang, M.H., Arthritis and Rheumatism, 1999, 10.1002/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F

Fine particulate air pollution, nitrogen dioxide, and systemic autoimmune rheumatic disease in Calgary, Alberta, Joseph, L., Bélisle, P., Edworthy, S., Fortin, P.R., Clarke, A.E., Hudson, M., Bertazzon, S., Brand, A., Svenson, L., Barnabe, C., Kaplan, G.G., Johnson, M., Smargiassi, A., Bernatsky, S., Environmental Research, 2015, 10.1016/j.envres.2015.05.007

The relationship between cancer and medication exposures in systemic lupus erythaematosus: A case-cohort study, Clarke, A.E., Ramsey-Goldman, R., Manzi, S., Zummer, M., Sénécal, J.-L., Rajan, R., Dooley, M.-A., Aranow, C., Alarcón, G.S., Petri, M., Rahman, A., Isenberg, D., Edworthy, S., Barr, S., Bae, S.-C., Ginzler, E., Fortin, P.R., Gladman, D., Urowitz, M., Gordon, C., Boivin, J.-F., Joseph, L., Bernatsky, S., Annals of the Rheumatic Diseases, 2008, 10.1136/ard.2006.069039

Surveillance of systemic autoimmune rheumatic diseases using administrative data, Joseph, L., Bergeron, L., Lagace, C., Bélisle, P., Smith, M., Fortin, P.R., Clarke, A.E., Pineau, C.A., Peschken, C., Badley, E., Hudson, M., Hanly, J.G., Lix, L., Bernatsky, S., Rheumatology International, 2011, 10.1007/s00296-010-1591-2

Challenges of Perceived Self‐Management in Lupus, Murray Rochon, J. Antonio Avina‐Zubieta, Stephanie Keeling, Ann E. Clarke, Janet E. Pope, Mark Matsos, Doug Smith, Marie Hudson, Evelyne Vinet, Christine A. Peschken, Davy Eng, Anna‐Lisa Morrison, Jodie Nimigon‐Young, Wendy Singer, Vinita Haroun, Elham Rahme, Anne‐Sophie Julien, Carolyn Neville, Deborah Da Costa, Paul R. Fortin, Arthritis Care & Research, 2022, 10.1002/acr.24542

Examination of the association of sex and race/ethnicity with appearance concerns: A Scleroderma Patient-centered Intervention Network (SPIN) Cohort study, Persmann, J., Pepin, M.R., Milette, K., Levis, B., Fedoruk, C., Delisle, V.C., Wilcox, P., Varga, J., Thorne, C., Sutton, E., Spiera, R., Smith, D., Schiopu, E., Roux, S., Robinson, D., Masetto, A., Liang, P., Korman, B., Khalidi, N., Kafaja, S., Fernandes, A.J.B., Jones, N., Ikic, A., Hinchcliff, M., Manning, J., Herrick, A.L., Gyger, G., Gordon, J., Gill, A., Fortin, P., Dunne, J.V., Domsic, R., Denton, C.P., Dagenais, P., Chung, L., Carreira, P., Bruns, A., Boire, G., Bissonnette, L., Arsenault, G., Albert, A., Wong-Rieger, D., Welling, J., Suarez-Almazor, M.E., Steele, R.J., Schouffoer, A.A., Reyna, T.S.R., Portales, A., Pope, J., Poole, J.L., Nielsen, K., Marra, C., Leite, C., Larche, M., Kennedy, A.T., Jang, Y., Impens, A., Hudson, M., Harel, D., Godard, D., Frech, T., Fortune, C., Fligelstone, K., van den Ende, C., Ells, C., El-Baalbaki, G., Maia, A.C., Boutron, I., Wigley, F., Sauve, M., Riggs, R., Poiraudeau, S., Nielson, W.R., Mouthon, L., Khanna, D., van den Hoogen, F., Baron, M., Thombs, B.D., Rice, D.B., Molnar, J.C., Mills, S.D., Gholizadeh, S., Fox, R.S., Steen, V., Körner, A., Johnson, S.R., Williamson, H., Harcourt, D., Assassi, S., Mayes, M.D., Gottesman, K., Furst, D.E., Bartlett, S.J., Malcarne, V.L., Carrier, M.-E., Kwakkenbos, L., Jewett, L.R., Clinical and Experimental Rheumatology, 2016

Breast cancer in systemic lupus erythematosus, Bernatsky, S., Sturfelt, G., Dreyer, L., Barr, S.G., Criswell, L.A., Witte, T., Nived, O., Jacobsen, S., Hanly, J.G., Ruiz-Irastorza, G., Rahman, A., Isenberg, D., Bae, S.C., Peschken, C.A., Senécal, J.L., Dooley, M.A., Edworthy, S., Labrecque, J., Ginzler, E.M., Manzi, S., Petri, M., Fortin, P.R., Wallace, D.J., Gladman, D., Urowitz, M.B., Yelin, E., Hansen, J.E., Gordon, C., Foulkes, W., Wang, Y., Ramsey-Goldman, R., Clarke, A.E., Tessier Cloutier, B., Oncology (Switzerland), 2013, 10.1159/000353138

Ten-year absolute fracture risk and hip bone strength in Canadian women with systemic lupus erythematosus, Fortin, P.R., Pope, J., Pineau, C., DaCosta, D., Hewitt, S., Neville, C., Peeva, V., Cymet, A., Morrison, S., Cheung, A.M., Aghdassi, E., Lee, J.J.Y., Journal of Rheumatology, 2012, 10.3899/jrheum.111589

Systematic review of validation studies of the use of administrative data to identify serious infections, Fortin, P.R., Lacaille, D., Barber, C., Arthritis Care and Research, 2013, 10.1002/acr.21959

Autoantibodies as biomarkers for the prediction of neuropsychiatric events in systemic lupus erythematosus, Merrill, J.T., Theriault, C., Thompson, K., Peschken, C., Farewell, V., Kamen, D., Lim, S., Petri, M., Ruiz-Irastorza, G., Fessler, B.J., Alarcoń, G.S., Kalunian, K., Mackay, M., Aranow, C., Ramos-Casals, M., Van Vollenhoven, R., Nived, O., Sturfelt, G., Ramsey-Goldman, R., Manzi, S., Khamashta, M., Steinsson, K., Bruce, I., Dooley, M.A., Sanchez-Guerrero, J., Romero-Dirz, J., Gladman, D., Fortin, P.R., Wallace, D.J., Rahman, A., Isenberg, D., Vasudevan, A., Bernatsky, S., Clarke, A., Gordon, C., Bae, S.-C., Su, L., Urowitz, M.B., Hanly, J.G., Annals of the Rheumatic Diseases, 2011, 10.1136/ard.2010.148502

Unpacking early work experiences of young adults with rheumatic disease: An examination of absenteeism, job disruptions, and productivity loss, Gignac, M.A.M., Shiff, N.J., Fortin, P.R., Beaton, D., Badley, E., Jetha, A., Arthritis Care and Research, 2015, 10.1002/acr.22601

Patient expectations and total joint arthroplasty [1] (multiple letters), Katz, J.N., Fortin, P.R., Daltroy, L.H., Liang, M.H., Mahomed, N.N., Dieppe, P., Donovan, J., Woolhead, G., Journal of Rheumatology, 2003

Study of Flare Assessment in Systemic Lupus Erythematosus Based on Paper Patients, Gordon, C., Merrill, J., Zoma, A., Wallace, D.J., van Vollenhoven, R., Urowitz, M., Sturfelt, G., Steinsson, K., Sanchez-Guerrero, J., Ruiz-Irastorza, G., Romero-Diaz, J., Ramsey-Goldman, R., Rahman, A., Kalunian, K., Petri, M., Peschken, C., Nived, O., Manzi, S., Lim, S., Khamashta, M., Kamen, D., Jacobsen, S., Inanc, M., Hanly, J., Gladman, D., Ginzler, E., Fortin, P., Dooley, M.A., Clarke, A., Cervera, R., Buyon, J., Bruce, I., Bernatsky, S., Sang-Cheol, B., Askanase, A., Aranow, C., Allen, E., Sturgess, J., Isenberg, D., Arthritis Care and Research, 2018, 10.1002/acr.23252

Designing an intervention for women with systemic lupus erythematosus from medically underserved areas to improve care: A qualitative study, Costenbader, K.H., Massarotti, E., Fortin, P.R., Todd, D.J., Fraser, P., Bermas, B.L., Zibit, M., Feldman, C.H., Lupus, 2013, 10.1177/0961203312463979

Platelets release pathogenic serotonin and return to circulation after immune complex-mediated sequestration, Boilard, E., Fortin, P.R., Lacroix, S., Newman, P.J., Flick, M.J., Khan, W.I., Nieswandt, B., Cote, F., McKenzie, S.E., Flamand, L., Italiano, J.E., Rondina, M.T., Poirier, G., Zhi, H., Melki, I., Tessandier, N., Becker, Y., Levesque, T., Zufferey, A., Mailhot, B., Machlus, K.R., Marcoux, G., Allaeys, I., Cloutier, N., Proceedings of the National Academy of Sciences of the United States of America, 2018, 10.1073/pnas.1720553115

α1-antitrypsin deficiency and systemic necrotizing vasculitis, Esdaile, J.M., Watts, C.S., Fraser, R.S., Fortin, P.R., Journal of Rheumatology, 1991

Psychosocial contributors to mental and physical health in patients with systemic lupus erythematosus, Clarke, A.E., Danoff, D.S., Esdaile, J.M., Joseph, L., Fortin, P.R., Dobkin, P.L., Arthritis and Rheumatism, 1998, 10.1002/art.1790110105

Occupational and environmental exposures and risk of systemic lupus erythematosus: Silica, sunlight, solvents, Fortin, P.R., Rioux, J.D., Clarke, A., Claudio, J.O., Bernatsky, S., Wither, J., Cooper, G.S., Rheumatology, 2010, 10.1093/rheumatology/keq214

Seizure disorders in systemic lupus erythematosus results from an international, prospective, inception cohort study, Farewell, V., Thompson, K., Theriault, C., Inanc, M., Peschken, C.A., Kamen, D.L., Lim, S., Kalunian, K.C., Ruiz-Irastorza, G., Van Vollenhoven, R.F., Ramos-Casals, M., Mackay, M., Aranow, C., Nived, O., Sturfelt, G.K., Zoma, A.A., Manzi, S., Ramsey-Goldman, R., Fessler, B.J., Alarcón, G.S., Khamashta, M.A., Dooley, M.A., Steinsson, K., Bruce, I.N., Gladman, D.D., Fortin, P.R., Petri, M., Rahman, A., Isenberg, D.A., Merrill, J.T., Ginzler, E.M., Clarke, A.E., Wallace, D.J., Romero-Diaz, J., Sanchez-Guerrero, J., Bae, S.-C., Gordon, C., Su, L., Urowitz, M.B., Hanly, J.G., Annals of the Rheumatic Diseases, 2012, 10.1136/annrheumdis-2011-201089

Altered expression of TNF-α signaling pathway proteins in systemic lupus erythematosus, Wither, J.E., Fortin, P.R., Urowitz, M.B., Gladman, D.D., Yu, X.-Q., Yang, X., Li, T., Landolt-Marticorena, C., Zhu, L.-J., Journal of Rheumatology, 2010, 10.3899/jrheum.091123

Determinants of discordance between patients and physicians in their assessment of lupus disease activity, Fortin, P.R., Battista, R.N., Clarke, A.E., Dobkin, P.L., Abrahamowicz, M., Yen, J.C., Journal of Rheumatology, 2003

Quality assurance and audit: Lessons from North America, Fortin, P., Liang, M.H., Annals of the Rheumatic Diseases, 1991, 10.1136/ard.50.7.522

Pilot study of anti-mitochondrial antibodies in antiphospholipid syndrome, Fortin, P.R., Boilard, É., Godbout, A., Julien, A.-S., Becker, Y.L.C., Lupus, 2020, 10.1177/0961203320944481

Mortality in systemic lupus erythematosus, Ramsey-Goldman, R., Clarke, A., St. Pierre, Y., McCarthy, T., El-Gabalawy, H., Sibley, J., Rahman, A., Edworthy, S., Pope, J., Ensworth, S., Hanly, J., Zummer, M., Senécal, J.-L., Alarcón, G., Steinsson, K., Sturfelt, G., Nived, O., Dooley, M.-A., Aranow, C., Zoma, A., Isenberg, D., Bae, S.-C., Gordon, C., Barr, S., Petri, M., Fortin, P.R., Urowitz, M., Gladman, D.D., Ginzler, E., Manzi, S., Joseph, L., Boivin, J.-F., Bernatsky, S., Arthritis and Rheumatism, 2006, 10.1002/art.21955

Peripheral Neuropathy in Patients with Systemic Lupus Erythematosus, Fortin, P.R., Urowitz, M.B., Gladman, D.D., Su, J., Aghdassi, E., Florica, B., Seminars in Arthritis and Rheumatism, 2011, 10.1016/j.semarthrit.2011.04.001

Non-lymphoma hematological malignancies in systemic lupus erythematosus, Clarke, A.E., Lee, J.L., Dreyer, L., Sturfelt, G., Criswell, L.A., Gottesman, L., Nived, O., Alarcón, G.S., Peschken, C.A., Dooley, M.A., Jacobsen, S., Wallace, D.J., Bae, S.-C., Yelin, E., Ginzler, E.M., Fortin, P.R., Gladman, D., Urowitz, M.B., Manzi, S., Petri, M., Ramsey-Goldman, R., Bernatsky, S., Lu, M., Oncology (Switzerland), 2013, 10.1159/000350165

The American College of Rheumatology response criteria for proliferative and membranous renal disease in systemic lupus erythematosus clinical trials, Wallace, D.J., Singh, A., Schneider, M.K., Ponticelli, C., Nived, O., Meyrier, A., Lundberg, I.E., Gordon, C.P., Finckh, A., Dooley, M.A., De Pablo, P., Crofford, L., Costenbader, K., Balow, J.E., St.Clair, E.W., Fortin, P., Schur, P.H., Liang, M.H., Arthritis and Rheumatism, 2006, 10.1002/art.21625

Quality of life in systemic lupus erythematosus patients during more and less active disease states: Differential contributors to mental and physical health, Clarke, A.E., Zummer, M., Smith, D., Gladman, D., Esdaile, J.M., Ensworth, S., Barr, S., Edworthy, S., Cividino, A., Beaulieu, A., Rich, E., Choquette, D., Goulet, J.-R., Senécal, J.-L., Fortin, P.R., Dritsa, M., Da Costa, D., Dobkin, P.L., Arthritis Care and Research, 1999, 10.1002/1529-0131(199912)12:6<401::aid-art8>3.0.co;2-f

Electrocardiographic findings in systemic lupus erythematosus: Data from an international inception cohort, Pineau, C.A., Zoma, A., Petri, M., Ramos-Casals, M., Kalunian, K., Sturfelt, G., Nived, O., Dooley, M.A., Ginzler, E., Bruce, I.N., Steinsson, K., Alarcón, G.S., Fessler, B., Sanchez-Guerrero, J., Romero-Diaz, J., Merrill, J.T., Fortin, P.R., Gladman, D.D., Rahman, A., Isenberg, D., Gordon, C., Wallace, D.J., Hanly, J.G., Bae, S.-C., Belisle, P., Joseph, L., Huynh, T., Krantz, M.J., Bernatsky, S., Clarke, A.E., Urowitz, M.B., Bourré-Tessier, J., Arthritis Care and Research, 2015, 10.1002/acr.22370

Monospecific anti-Ro52/TRIM21 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects: Evidence of an association with interstitial lung disease and worse survival, Salazar, G., McNearney, T.A., Mayes, M.D., Assassi, S., Zochling, J., Walker, J., Stevens, W., Sahhar, J., Rischmueller, M., Proudman, S., Patterson, K., Roddy, J., Nash, P., Lester, S., Hill, C., Fritzler, M.J., Cabral, A.R., Rodriguez-Reyna, T.S., Larché, M., Fortin, P.R., Smith, D., Gyger, G., Thorne, C., LeClercq, S., Grodzicky, T., Ligier, S., Mathieu, J.-P., Sutton, E., Masetto, A., Kaminska, E., Docherty, P., Khalidi, N., Jones, N., Robinson, D., Markland, J., Pope, J., Fritzler, M.J., Baron, M., Wang, M., Mayes, M.D., Assassi, S., Nikpour, M., Stevens, W., Walker, J., Proudman, S., Hudson, M., Wodkowski, M., Clinical and Experimental Rheumatology, 2015

A targeted association study in systemic lupus erythematosus identifies multiple susceptibility alleles, Rioux, J.D., Wither, J., Fortin, P.R., Zummer, M., Barr, S.G., Boire, G., Rich, E., Hanly, J., Smith, C.D., Peschken, C., Pope, J.E., Clarke, A.E., Gladman, D., Hudson, T., Claudio, J.O., Graham, R.R., Lian, J., Boucher, G., Goyette, P., Budarf, M.L., Genes and Immunity, 2011, 10.1038/gene.2010.47

Development and Acceptability of a Patient Decision Aid for Pain Management in Juvenile Idiopathic Arthritis: The JIA Option Map, Décary, S., Gmuca, S., Weiss, J.E., Connelly, M., Brinkman, W., Fortin, P.R., Gibbon, M., Ueffing, E., Cavallo, S., Stringer, E., El Hindi, T., Ragusa, M., Sivakumar, A., Sirois, A., Sachs, H., Boyd, A., Berbatovci, F., Couchman, D., Stinson, J., Tugwell, P., Li, L.C., Gaboury, I., Cohen, J.S., Morgan, E.M., Proulx, L., Duffy, C.M., Huber, A.M., Toupin-April, K., Patient, 2020, 10.1007/s40271-020-00458-z

"What do you expect? You're just getting older": A comparison of perceived osteoarthritis-related and aging-related health experiences in middle- and older-age adults, Badley, E.M., Fortin, P.R., Mahomed, N., Wright, J.G., Hawker, G., Davis, A.M., Gignac, M.A.M., Arthritis Care and Research, 2006, 10.1002/art.22338

Role of radiation therapy in patients with a diagnosis of both systemic lupus erythematosus and cancer, Fortin, P.R., Urowitz, M., Gladman, D., Al-Herz, A., Benk, V., Arthritis Care and Research, 2005, 10.1002/art.20912

Clinical and serologic factors associated with lupus pleuritis, Peschken, C.A., Huber, A., Ramsey, S., Berkson, L., Baron, M., Scuccimarri, R., Duffy, K., Campillo, S., Chedéville, G., Albert, L., Cooper, G.S., Petty, R.E., Tucker, L.B., Hudson, M., Bernatsky, S., Clarke, A.E., Zummer, M., Urowitz, M.B., Gladman, D.D., Arbillaga, H., Smith, C.D., Pineau, C., Fortin, P.R., Pope, J.E., Silverman, E.D., Hitchon, C.A., Gelber, A.C., Mittoo, S., Journal of Rheumatology, 2010, 10.3899/jrheum.090249

Association of autoantibodies to nuclear lamin B1 with thromboprotection in systemic lupus erythematosus: Lack of evidence for a direct role of lamin B1 in apoptotic blebs, Raymond, Y., Brassard, N., Fortin, P., Hanly, J.G., Rauch, J., Senécal, J.-L., Dieudé, M., Arthritis and Rheumatism, 2002, 10.1002/art.10552

The non-haemostatic role of platelets in systemic lupus erythematosus, Boilard, E., Bengtsson, A.A., Lood, C., Fortin, P.R., Linge, P., Nature Reviews Rheumatology, 2018, 10.1038/nrrheum.2018.38

The use of micronutrient supplements is not associated with better quality of life and disease activity in Canadian patients with systemic lupus erythematosus, Fortin, P.R., Wither, J., DaCosta, D., Peschken, C., Pope, J., Urowitz, M., Gladman, D., Pineau, C.A., Su, J., Landolt-Marticorena, C., Morrison, S., Aghdassi, E., Journal of Rheumatology, 2010, 10.3899/jrheum.090761

Living with lupus: A prospective Pan-Canadian study, Clarke, A.E., Gladman, D., Zummer, M., Smith, D., Ensworth, S., Cividino, A., Beaulieu, A., Rich, E., Choquette, D., Goulet, J.-R., Senécal, J.-L., Esdaile, J.M., Barr, S., Edworthy, E., Fortin, P.R., Da Costa, D., Dobkin, P.L., Journal of Rheumatology, 2001

Low aspirin use and high prevalence of pre-eclampsia risk factors among pregnant women in a multinational SLE inception cohort, Vinet, E., Costedoat-Chalumeau, N., Bruce, I.N., Sanchez-Guerrero, J., Askanase, A., Jacobsen, Sø., Peschken, C.A., Kamen, D.L., Inanc, M., Kalunian, K.C., Lim, S., Ruiz-Irastorza, G., Ramos-Casals, M., Van Vollenhoven, R.F., Zoma, A.A., Jönsen, A., Nived, O., Manzi, S., Alarcón, G.S., Mackay, M., Aranow, C., Khamashta, M.A., Ramsey-Goldman, R., Steinsson, K., Gladman, D.D., Fortin, P.R., Dooley, M.A., Petri, M., Ginzler, E.M., Rahman, A., Isenberg, D.A., Buyon, J.P., Merrill, J.T., Wallace, D.J., Bae, S.-C., Gordon, C., Romero-Diaz, J., Clarke, A.E., Urowitz, M.B., Hanly, J.G., Bernatsky, S.B., Mendel, A., Annals of the Rheumatic Diseases, 2019, 10.1136/annrheumdis-2018-214434

Validation of the Self-Efficacy for Managing Chronic Disease Scale: A Scleroderma Patient-Centered Intervention Network Cohort Study, Mills, S.D., Pepin, M.R., Milette, K., Levis, B., Jewett, L.R., Fedoruk, C., Gholizadeh, S., Fox, R.S., Delisle, V.C., Wilcox, P., Varga, J., Thorne, C., Steen, V., Spiera, R., Smith, D., Roux, S., Schiopu, E., Robinson, D., Masetto, A., Liang, P., Korman, B., Larche, M., Khalidi, N., Kafaja, S., Fernandes, A.J.D.B., Jones, N., Hinchcliff, M., Herrick, A., Gyger, G., Gordon, J., Fortin, P., Dunne, J.V., Domsic, R., Denton, C., Dagenais, P., Chung, L., Carreira, P., Arsenault, G., Albert, A., Wong-Rieger, D., Welling, J., Steele, R.J., Schouffoer, A.A., Sofia Rodriguez Reyna, T., Poole, J.L., Portales, A., Marra, C., Leite, C., Körner, A., Tyrell Kennedy, A., Johnson, S.R., Jang, Y., Impens, A., Harel, D., Godard, D., Fortune, C., Fligelstone, K., van den Ende, C.H.M., Ells, C., El-Baalbaki, G., Costa Maia, A., Boutron, I., Assassi, S., van den Hoogen, F., Riggs, R., Mayes, M.D., Gottesman, K., Furst, D., Thombs, B.D., Wigley, F.M., Suarez-Almazor, M.E., Sauve, M., Pope, J., Hudson, M., Frech, T., Baron, M., Nielsen, K., Poiraudeau, S., Nielson, W.R., Mouthon, L., Malcarne, V.L., Bartlett, S.J., Carrier, M.-E., Kwakkenbos, L., Riehm, K.E., Arthritis Care and Research, 2016, 10.1002/acr.22807

The scleroderma patient-centered intervention network cohort: Baseline clinical features and comparison with other large scleroderma cohorts, Turner, K., Persmann, J., Pepin, M.R., Mills, S.D., Levis, B., Jewett, L.R., Gholizadeh, S., Fox, R.S., Fedoruk, C., Delisle, V.C., Cumin, J., Wong-Rieger, D., Wigley, F., Welling, J., Varga, J., Suarez-Almazor, M.E., Steele, R.J., Smith, D., Schouffoer, A.A., Roux, S., Reyna, T.S.R., Robinson, D., Riggs, R., Portales, A., Nielsen, K., Masetto, A., Marra, C., Liang, P., Leite, C., Korman, B., Khalidi, N., Kennedy, A.T., Fernandes, A.J.D.B., Jang, Y., Impens, A., Ikic, A., Harel, D., Gyger, G., Godard, D., Fortune, C., Fligelstone, K., Van Den Ende, C., Ells, C., El-Baalbaki, G., Domsic, R., Dagenais, P., Maia, A.C., Carreira, P., Boutron, I., Bissonette, L., Arsenault, G., Albert, A., Mayes, M.D., Thombs, B.D., Wilcox, P., Thorne, C., Sutton, E., Steen, V., Spiera, R., Pope, J., Manning, J., Larché, M., Kafaja, S., Jones, N., Johnson, S.R., Hudson, M., Hinchcliff, M., Herrick, A.L., Gordon, J., Gill, A., Frech, T., Fortin, P., Dunne, J.V., Denton, C., Chung, L., Bruns, A., Boire, G., Sauvé, M., Poiraudeau, S., Nielson, W.R., Mouthon, L., Malcarne, V.L., Van Den Hoogen, F., Gottesman, K., Furst, D.E., Bartlett, S.J., Baron, M., Assassi, S., Salazar, G., Carrier, M.-E., Kwakkenbos, L., Dougherty, D.H., Rheumatology (United Kingdom), 2018, 10.1093/rheumatology/key139

Canadian rheumatology association recommendations for the assessment and monitoring of systemic lupus erythematosus, Santesso, N., Vinet, E., Touma, Z., Urowitz, M., Suitner, M., Tselios, K., Silverman, E., Reynolds, J., Rader, T., Pope, J., Pineau, C., Peschken, C., Pardi, J.P., Medina-Rosas, J., McDonald, E.G., Matsos, M., Lim, L., Levy, D., Legault, K., Hussein, S., Hiraki, L.T., Hanly, J.G., Haaland, D., Gladman, D.D., Fortin, P.R., Fifi-Mah, A., Ensworth, S., Dutz, J., Baril-Dionne, A., Clarke, A., Bourre-Tessier, J., Bernatsky, S., Bergeron, L., Barr, S., Avina-Zubieta, A., Alabdurubalnabi, Z., Keeling, S.O., Journal of Rheumatology, 2018, 10.3899/jrheum.171459

Interferon-α induces altered transitional B cell signaling and function in Systemic Lupus Erythematosus, Wither, J.E., Urowitz, M.B., Gladman, D.D., Fortin, P.R., Landolt-Marticorena, C., Kim, J.J., Li, T.T., Chang, N.-H., Journal of Autoimmunity, 2015, 10.1016/j.jaut.2015.01.009

The persistence of anticardiolipin antibodies is associated with an increased risk of the presence of lupus anticoagulant and anti-β2-glycoprotein I antibodies, Fortin, P.R., Chang, E.R., Subang, R., Belisle, P., Joseph, L., Solymoss, S., Kassis, J., Rauch, J., Neville, C., Rheumatology, 2006, 10.1093/rheumatology/kel050

Practice variations in the diagnosis, monitoring, and treatment of systemic lupus erythematosus in Canada, Urowitz, M.B., Peschken, C., Gladman, D.D., Fortin, P.R., Vandermeer, B., Bernatsky, S., Bissonauth, A., Keeling, S.O., Journal of Rheumatology, 2018, 10.3899/jrheum.171307

Discontinuation of antimalarial drugs in systemic lupus erythematosus, Esdaile, J.M., Gans, M., Panaritis, T., Li, Y., Fortin, P.R., Wang, C., Journal of Rheumatology, 1999

Expanded population of activated antigen-engaged cells within the naive B cell compartment of patients with systemic lupus erythematosus, Wither, J.E., Urowitz, M., Gladman, D., Fortin, P.R., Landolt-Marticorena, C., Bonventi, G., McKenzie, T., Chang, N.-H., Journal of Immunology, 2008, 10.4049/jimmunol.180.2.1276

Cluster analysis for the identification of clinical phenotypes among antiphospholipid antibody-positive patients from the APS ACTION Registry, Erkan, D., Wahl, D., Vega, J., Bertolaccini, M.L., Willis, R., Atsumi, T., Knight, J.S., Cervera, R., Rodriguez, E., Petri, M., Nalli, C., Jesus, G.R.D., Branch, D.W., Cohen, H., Efthymiou, M., Ji, L., Fortin, P., Zamorano, M.A.A., Michael Belmont, H., Gerosa, M., Ugarte, A., Tektonidou, M.G., Pengo, V., Sciascia, S., Andrade, D., Bauman, C., Clerc-Urmès, I., Zuily, S., Lupus, 2020, 10.1177/0961203320940776

Antinuclear Antibody–Negative Systemic Lupus Erythematosus in an International Inception Cohort, Fritzler, M.J., Mahler, M., Buyon, J., Stoll, T., Askanase, A., Jacobsen, S., Peschken, C.A., Kamen, D.L., Inanc, M., Kalunian, K.C., Lim, S.S., Ruiz-Irastorza, G., Ramos-Casals, M., van Vollenhoven, R.F., Zoma, A.A., Nived, O., Manzi, S., Alarcón, G.S., Aranow, C., Khamashta, M.A., Ramsey-Goldman, R., Steinsson, K., Sanchez-Guerrero, J., Gladman, D.D., Fortin, P.R., Dooley, M.A., Bruce, I.N., Petri, M., Ginzler, E.M., Rahman, A., Isenberg, D.A., Merrill, J.T., Wallace, D.J., Bernatsky, S., Bae, S.-C., Gordon, C., Romero-Diaz, J., Urowitz, M.B., Hanly, J.G., St. Pierre, Y., Clarke, A.E., Choi, M.Y., Arthritis Care and Research, 2019, 10.1002/acr.23712

Clinical correlates of faecal incontinence in systemic sclerosis: Identifying therapeutic avenues, Fritzler, M., Cabral, A.R., Rodriguez-Reyna, T.S., Abu-Hakima, M., Fortin, P.R., Smith, D., Thorne, C., Sutton, E., Masetto, A., LeClercq, S., Kaminska, E., Docherty, P., Jones, N., Robinson, D., Markland, J., Gyger, G., Grodzicky, T., Ligier, S., Mathieu, J.-P., Masetto, A., Pope, J., Thorne, C., Fortin, P.R., Albert, A., Larché, M., Carrier, N., Pope, J.E., Khalidi, N., Sutton, E., Baron, M., Gyger, G., Hudson, M., Richard, N., Rheumatology (United Kingdom), 2017, 10.1093/rheumatology/kew441

Mammalian target of rapamycin is activated in the kidneys of patients with scleroderma renal crisis, Fritzler, M., Fortin, P.R., Thorne, C., Smith, D., Rodriguez-Reyna, T.S., Robinson, D., Sutton, E., Masetto, A., Khalidi, N., Larché, M., Pope, J., Gyger, G., Hudson, M., Baron, M., Hudson, M., Baron, M., Berkson, L., Del Rincon, S., Takano, T., Fiset, P., Patey, N., Salituri, J., Journal of Scleroderma and Related Disorders, 2019, 10.1177/2397198319885488

The needs of patients with arthritis: The patient's perspective, Esdaile, J.M., Du Berger, R., Abrahamowitz, M., Baron, M., Fitzcharles, M.-A., Fortin, P.R., Neville, C., Arthritis Care and Research, 1999, 10.1002/1529-0131(199904)12:2<85::aid-art3>3.0.co;2-w

Association of health-related quality of life in childhood-onset systemic lupus erythematosus with ethnicity: Results from a multiethnic multicenter canadian cohort, Moyen, M., Craig, A., Hitchon, C., Ouimet, J., Hewitt, S., Hanly, J., Bernstein, J., Berkson, L., Baron, M., Hudson, M., Wehlage, A., Arbillaga, H., Ferland, D., Zummer, M., Smith, K., Simpson, S., Smith, C.D., Santopietro, T., Tobaly, M., Bernatsky, S., Pineau, C., Clarke, A., McKenzie, T., Inman, R., Carette, S., Albert, L., Gladman, D., Urowitz, M., Fortin, P., Ng, L., Warner, A., Ramsey, S., Lang, B., Scuccimarri, R., Duffy, K., Campillo, S., Morishita, K., Houghton, K., Cabral, D., Petty, R., Silverman, E.D., Pope, J.E., Huber, A.M., Chédeville, G., Tucker, L.B., Peschken, C.A., Levy, D.M., Arthritis Care and Research, 2014, 10.1002/acr.22363

Effect of delay in initiating radiotherapy for patients with early stage breast cancer, Freeman, C.R., Levinton, C., Ho, V., Belisle, P., Zhang, G., Fortin, P., Joseph, L., Benk, V., Clinical Oncology, 2004, 10.1016/j.clon.2003.10.008

The frequency of and associations with hospitalization secondary to lupus flares from the 1000 Faces of Lupus Canadian cohort, Pope, J.E., Fortin, P.R., Hitchon, C., Hudson, M., Bernatsky, S., Clarke, A., Zummer, M., Arbillaga, H., Smith, C.D., Pineau, C., Silverman, E., Muangchan, C., Peschken, C.A., Lee, J., Lupus, 2013, 10.1177/0961203313505689

Lymphoma risk in systemic lupus: Effects of disease activity versus treatment, Clarke, A.E., Pierre, Y.St., Patel, N.M., Dreyer, L., Feldman, C.H., Blanco, I., Sturfelt, G.K., Criswell, L.A., Barr, S.G., Witte, T., Askanase, A., Romero-Diaz, J., Kamen, D.L., Aranow, C., Edworthy, S.M., Dooley, M.A., Peschken, C.A., Wallace, D.J., Bae, S.-C., Yelin, E., Ruiz-Irastorza, G., Gordon, C., Rahman, A., Isenberg, D., Ginzler, E.M., Manzi, S., Jacobsen, S., Petri, M.A., Nived, O., Fortin, P.R., Gladman, D.D., Urowitz, M.B., Costenbader, K.H., Boivin, J.-F., Joseph, L., Ramsey-Goldman, R., Bernatsky, S., Annals of the Rheumatic Diseases, 2014, 10.1136/annrheumdis-2012-202099

Smoking is the most significant modifiable lung cancer risk factor in systemic lupus erythematosus, Clarke, A.E., Pierre, Y.S., Hansen, J.E., Rahman, A., Isenberg, D., Bae, S.-C., Aranow, C., Nived, O., Gordon, C., Peschken, C., Hanly, J.G., Ginzler, E., Yelin, E.H., Fortin, P.R., Gladman, D.D., Urowitz, M.B., Petri, M., Ramsey-Goldman, R., Bernatsky, S., Journal of Rheumatology, 2018, 10.3899/jrheum.170652

Persistent proteinuria and dyslipidemia increase the risk of progressive chronic kidney disease in lupus erythematosus, Fortin, P.R., Scholey, J.W., Landolt-Marticorena, C., Wither, J., Cattran, D.C., Herzenberg, A.M., Su, J., Fan, S.C.P., Lou, W., Hladunewich, M.A., Bargman, J.M., Urowitz, M.B., Gladman, D.D., Reich, H.N., Kidney International, 2011, 10.1038/ki.2010.525

The protective effect of antimalarial drugs on thrombovascular events in systemic lupus erythematosus, Fortin, P.R., Lou, W., Urowitz, M., Gladman, D.D., Shariati-Sarabi, Z., Su, J., Bobba, R., Jung, H., Arthritis and Rheumatism, 2010, 10.1002/art.27289

Subsets in systemic sclerosis: One size does not fit all, Youssef, P., Walker, J., Roddy, J., Zochling, J., Sahhar, J., Nikpour, M., Rodriguez-Reyna, T.S., Larché, M., Fortin, P.R., Smith, D., Gyger, G., Thorne, C., Sutton, E., Masetto, A., Khalidi, N., Robinson, D., Markland, J., Baron, M., Pope, J., Wang, M., Fritzler, M.J., Stevens, W.M., Proudman, S.M., Hudson, M., Leclair, V., Journal of Scleroderma and Related Disorders, 2016, 10.5301/jsrd.5000212

Calcinosis is associated with digital ischaemia in systemic sclerosis-a longitudinal study, Hudson, M., Wang, M., Fritzler, M.J., Cabral-Castaneda, A.R., Rodriguez-Reyna, T.S., Abu-Hakima, M., Larché, M., Fortin, P.R., Smith, D., Gyger, G., Thorne, C., LeClercq, S., Grodzicky, T., Ligier, S., Mathieu, J.-P., Sutton, E., Masetto, A., Kaminska, E., Docherty, P., Khalidi, N., Jones, N., Robinson, D., Pope, J., Baron, M., Rheumatology (United Kingdom), 2016, 10.1093/rheumatology/kew313

Relationship between anti-double-stranded DNA antibodies and exacerbation of renal disease in patients with systemic lupus erythematosus, Zummer, M., Weaver, C., Wallace, D., Vilardell-Tarres, M., Vijayan, A., Varga, J., Van Vollenhoven, R., Tumlin, J., Torres, A., Tindall, E.A., Surbeck, W., Sturfelt, G., Stevens, M.P., Stern, S., Staud, R., Spira, M., Spinowitz, B., Smith, D., Sibilia, J., Sherrer, Y., Shergy, W.J., Sewell, L.K., Schousboe, J.T., Schneider, M., Scarpa, N., Rothfield, N., Rosenblatt, S.G., Ramsey-Goldman, R., Quinet, R.J., Poque, B.C., Petri, M., Neuwelt, M.C., Moreland, L.W., Merrill, J., McKay, J., Martin, K., Manzi, S., Loveless, J., Lourie, S.H., Lindberg, J.S., Liebling, M., Kurtzman, N.A., Krishnan, M., Kivitz, A.J., Khamashta, M., Kenney, H.M., Katz, R., Kaplan, S., Kaplan, J., Kanick, K., Kammer, G.M., Kalunian, K.C., Kalden, J.P., Jakes, J., Jaffer, A., Ingelmo, M., Hura, C., Howard, P., Hill, M., Hiepe, F., Grossman, J., Granda, J.L., Gluck, O.S., Ginzler, E., Gilkeson, G.S., Gil-Aguado, A., Geppert, T., Genovese, M.C., Furie, R.A., Fortin, P., Fondal, M., Finkel, T.H., Espinoza, L.R., Emery, P., El-Shahawy, M.A., Edwards, M., Desir, D., DeHoratius, R., Cush, J.J., Cronin, M.E., Condemi, J.J., Carteron, N.L., Cardiel, M.H., Buyon, J.P., Brelsford, W.G., Bombardieri, S., Boling, E.P., Bohan, A., Belmont, M.H., Becker, N., Becker, M.A., Ballou, S., Aranow, C., Appel, G., Alarcón-Segovia, D., Joh, T., Hurley, F.L., Strand, V., Heilbrunn, K.R., Hu, J.Z., Linnik, M.D., Arthritis and Rheumatism, 2005, 10.1002/art.20980

Completeness of reporting of trials published in languages other than English: Implications for conduct and reporting of systematic reviews, Penna, A., Linde, K., Liberati, A., Le Lorier, J., Klassen, T., Jüni, P., Jadad, A.R., Fortin, P., Moher, D., Lancet, 1996, 10.1016/S0140-6736(96)90538-3

Epidemiologic studies of rheumatoid arthritis: Future directions, Fortin, P.R., Heath Jr., C.W., Journal of Rheumatology, 1992

The systemic lupus erythematosus tri-nation study: Longitudinal changes in physical and mental well-being, Heaton, S., Rairie, J., Orsini-Dudin, M., Neville, C., Ferland, D., Trifero, M., Margonis, K., Panaritis, P., Panaritis, T., Clarke, A.E., Esdaile, J.M., Grodzicky, T., Choquette, D., Goulet, J.-R., Sutcliffe, N., Fortin, P.R., Pineau, C., St. Pierre, Y., Joseph, L., Penrod, J.R., Senecal, J.-L., Gordon, C., Isenberg, D.A., Manzi, S., Petri, M., Panopalis, P., Rheumatology, 2005, 10.1093/rheumatology/keh580

Psychosis in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study, Farewell, V., Theriault, C., Askanase, A., Kamen, D.L., Peschken, C.A., Jacobsen, S., Kalunian, K.C., Inanc, M., Lim, S.S., Ramos-Casals, M., Ruiz-Irastorza, G., Mackay, M., Aranow, C., van Vollenhoven, R.F., Alarcón, G.S., Khamashta, M.A., Jonsen, A., Nived, O., Manzi, S., Zoma, A.A., Ramsey-Goldman, R., Steinsson, K., Dooley, M.A., Ginzler, E., Petri, M., Bruce, I.N., Gladman, D.D., Fortin, P.R., Merrill, J.T., Rahman, A., Isenberg, D.A., Wallace, D.J., Clarke, A.E., Bernatsky, S., Sanchez-Guerrero, J., Romero-Diaz, J., Bae, S.-C., Gordon, C., Urowitz, M.B., Su, L., Li, Q., Hanly, J.G., Arthritis and Rheumatology, 2019, 10.1002/art.40764

Bicaudal D2 is a novel autoantibody target in systemic sclerosis that shares a key epitope with CENP-A but has a distinct clinical phenotype, Fritzler, M.J., Cabral, A.R., Rodriguez-Reyna, T.S., Abu-Hakima, M., Larché, M., Fortin, P.R., Smith, D., Gyger, G., Thorne, C., LeClercq, S., Grodzicky, T., Ligier, S., Hudson, M., Mathieu, J.-P., Sutton, E., Masetto, A., Kaminska, E., Docherty, P., Khalidi, N., Jones, N., Robinson, D., Markland, J., Baron, M., Pope, J., Baron, M., Milo, J., Bentow, C., Wang, M., Mahler, M., Choi, M.Y., Hudson, M., Fritzler, M.J., Autoimmunity Reviews, 2018, 10.1016/j.autrev.2018.01.006

Interstitial lung disease is associated with an increased risk of lung cancer in systemic sclerosis: Longitudinal data from the Canadian Scleroderma Research Group, Fritzler, M., Cabral, A.R., Rodriguez-Reyna, T.S., Abu-Hakima, M., Larché, M., Fortin, P.R., Smith, D., Gyger, G., Thorne, C., Leclercq, S., Grodzicky, T., Ligier, S., Hudson, M., Mathieu, J.-P., Sutton, E., Masetto, A., Kaminska, E., Docherty, P., Khalidi, N., Jones, N., Robinson, D., Pope, J., Markland, J., Bernatsky, S., Baron, M., Younanian, E., Wang, M., Sakr, L., Hudson, M., Journal of Scleroderma and Related Disorders, 2018, 10.1177/2397198318766825

Cancer risk in systemic lupus: An updated international multi-centre cohort study, Clarke, A.E., St. Pierre, Y., Sibley, J., Dreyer, L., McCarthy, T., El-Gabalawy, H., Ensworth, S., Pope, J.E., Zummer, M., Senécal, J.-L., Patel, N.M., Sturfelt, G., Criswell, L.A., Barr, S., Askanase, A., Steinsson, K., Kamen, D.L., Aranow, C., Witte, T., Rahman, A., Isenberg, D., Ruiz-Irastorza, G., Nived, O., Alarcón, G.S., Hanly, J.G., Peschken, C.A., Dooley, M.A., Gordon, C., Jacobsen, S., Edworthy, S., Wallace, D.J., Bae, S.-C., Yelin, E., Ginzler, E., Fortin, P.R., Gladman, D., Urowitz, M.B., Manzi, S., Zoma, A., Petri, M., Boivin, J.-F., Joseph, L., Labrecque, J., Ramsey-Goldman, R., Bernatsky, S., Journal of Autoimmunity, 2013, 10.1016/j.jaut.2012.12.009

Nitrated nucleosome levels and neuropsychiatric events in systemic lupus erythematosus; a multi-center retrospective case-control study, Rahman, A., Zoma, A., Wallace, D.J., van Vollenhoven, R., Sturfelt, G.K., Steinson, K., Sanchez-Guerrero, J., Ruiz-Irastorza, G., Ramsey-Goldman, R., Petri, M., Peschken, C., Nived, O., Merrill, J., Manzi, S., Lim, S., Khamashta, M., Kamen, D., Kalunian, K., Jacobsen, S., Inanc, M., Gordon, C., Gladman, D., Ginzler, E., Fortin, P., Dooley, M.A., Clarke, A.E., Buyon, J., Bruce, I.N., Bernatsky, S., Bae, S.-C., Askanase, A., Aranow, C., Anderson, N., Urowitz, M.B., Hanly, J.G., Ioannou, Y., Isenberg, D., Giles, I., Miller, S., Matharu, M., Raimondo, M.G., Croca, S., Ferreira, I., Arthritis Research and Therapy, 2017, 10.1186/s13075-017-1495-6

Familial antiphospholipid syndrome and HLA-DRB gene associations, Fortin, P.R., Kassis, J., Rauch, J., Busque, L., Hudson, N., Arthritis and Rheumatism, 1997, 10.1002/art.1780401030

Evaluation of clinical outcomes and renal vascular pathology among patients with lupus, Fortin, P.R., Reich, H., Gladman, D., Urowitz, M., Wither, J., Scholey, J.W., Thomas, D., Nasr, S.H., Yip, J., Qian, G., Lou, W., Su, J., Aghdassi, E., Herzenberg, A., Barber, C., Clinical Journal of the American Society of Nephrology, 2012, 10.2215/CJN.02870311

When Should I Get My Next COVID-19 Vaccine? Data From the Surveillance of Responses to COVID-19 Vaccines in Systemic Immune-Mediated Inflammatory Diseases (SUCCEED) Study, Sasha Bernatsky, Valeria Valerio, Elizabeth Turnbull, Lindsay Hracs, Joshua Quan, Sophie Roux, Hugues Allard-Chamard, Janet Gunderson, Nadine Lalonde, John Kim, Jenna Benoit, Diane Lacaille, Charles N. Bernstein, Mark S. Silverberg, Tania H. Watts, Daniel Pereira, Dawn P. Richards, Jennifer L.F. Lee, Luck Lukusa, Ines Colmegna, Roya M. Dayam, Anne-Claude Gingras, Gilles Boire, Maggie J. Larché, Paul R. Fortin, J. Antonio Avina-Zubieta, Gilaad G. Kaplan, Carol A. Hitchon, Vinod Chandran, Dawn M.E. Bowdish, The Journal of Rheumatology, 2024, 10.3899/jrheum.2023-1214

Response to Middleton KR et als. Yoga and SLE, Bernatsky, S., Neville, A., Neville, C., Fortin, P.R., Clarke, A.E., Da Costa, D., Pineau, C.A., Lee, J., Complementary Therapies in Medicine, 2019, 10.1016/j.ctim.2019.02.019

What have multicentre registries across the world taught us about the disease features of systemic sclerosis?, Ng, S.C., Lim, A.Y.N., Chan, G., Teng, G., Low, A.H.L., Cosentino, V., Montoya, F., Kerzberg, E., Karpec, D., Rugiene, R., Venalis, P., Butrimiene, I., Venalis, A., Litinsky, I., Chifflot, H., Gottenberg, J.E., Chatelus, E., Sibilia, J., Exposito, M.V., Rubio, S.R., Kafaja, S., García de la Peña Lefebvre, P., Furst, D.E., Ancuta, C., Chirieac, R., Tiglea, I., Dumitrascu, A., Popescu, M., Tanaseanu, C.-M., Pisarri, S., Rosato, E., Loyo, E., O’Rourke, M., Veale, D., Doube, A., Solanki, K., O’Donnell, J., Chapman, P., Stamp, L., Highton, J., Stebbings, S., Zenone, T., Russu, E., Chiaburu, L., Groppa, L., Agachi, S., Azevedo, V.F., de Souza Müller, C., Radominski, S.C., Mayer, M., Baresic, M., Anic, B., Günther, C., Aringer, M., Saar, P., Krummel-Lorenz, B., Morgiel, E., Sokolik, R., Szmyrka-Kaczmarek, M., Wiland, P., Szechinski, J., Knott, E., Hein, R., Eyerich, K., Pozzi, M.R., Iversen, L., Ullman, S., Corrado, A., Cantatore, F.P., Smith, V., De Keyser, F., Mouthon, L., Zeni, S., Meroni, P., Distler, J.H., Schett, G., Bojinca, M., Dobrota, R., Gorga, M., Gherghe, A.M., Ionitescu, R., Cornateanu, R.S., Mihai, C.M., Wigley, F.M., Groseanu, L., Opris, D., Ionescu, R.M., Riccieri, V., Valesini, G., Launay, D., Garen, T., Midtvedt, Ø., Giraldo, W.A.S., de la Puente Buijdos, C., Mendoza, A.Z., Szücs, G., Damgaard, K., Nielsen, H., Strauss, G., Engelhart, M., Starovoytova, M.N., Tikly, M., Stankovic, A., Stamenkovic, B., Salvador, M.J., Himsel, A., Burkhardt, H., Oleszowsky, M., Seidel, M., Krasowska, D., Heitmann, S., Santamaria, V.O., Henes, J., Denton, C., Black, C., Caramaschi, P., Bambara, L.M., Pellerito, R., Hunzelmann, N., Lo Monaco, A., Govoni, M., Martinovic, D., Wollheim, F., Scheja, A., Hesselstrand, R., Hij, A., Farge, D., Gabrielli, A., Coleiro, B., Mallia, C., Rozman, B., Widuchowska, M., Kopec-Medrek, M., Kotulska, A., Kucharz, E.J., Chizzolini, C., Varju, C., Czirják, L., Novak, S., Caporali, R., Montecucco, C., Vlachoyiannopoulos, P., Nicoara, I., Rednic, S., Vettori, S., Cuomo, G., Sulli, A., Cutolo, M., Sierakowsky, S., Becvar, R., Iannone, F., Lapadula, G., Tyndall, A., Maurer, B., Müller-Ladner, U., Li, M., Busquets, J., Jimenez, S., Scorza, R., Ananieva, L.P., Damjanov, N., Braun-Moscovici, Y., Gurman, A.B., Cozzi, F., Carreira, P.E., Valentini, G., Hachulla, E., Air, P., Riemekasten, G., Guiducci, S., Walker, U.A., Avouac, J., Fritzler, M., Cabral, A.R., Rodriguez-Reyna, T.S., Abu-Hakima, M., Larché, M., Fortin, P.R., Smith, D., Gyger, G., Thorne, C., LeClercq, S., Grodzicky, T., Ligier, S., Hudson, M., Mathieu, J.-P., Sutton, E., Masetto, A., Kaminska, E., Docherty, P., Khalidi, N., Jones, N., Robinson, D., Markland, J., Pope, J., Zochling, J., Walker, J., Thakkar, V., Strickland, G., Roddy, J., Rischmueller, M., Proudman, S., Ngian, G.-S., Nash, P., Lester, S., Hill, C., Nikpour, M., Santosa, A., Law, W.G., Teng, G.G., H.L. Low, A., Matucci-Cerinic, M., Kowal-Bielecka, O., Distler, O., Allanore, Y., Pope, J., Hudson, M., Baron, M., Sahhar, J., Wilson, M.E., Stevens, W., Huq, M., Proudman, S.M., Journal of Scleroderma and Related Disorders, 2017, 10.5301/jsrd.5000256

Using Marital Status and Continuous Marital Satisfaction Ratings to Predict Depressive Symptoms in Married and Unmarried Women With Systemic Sclerosis: A Canadian Scleroderma Research Group Study, Fortin, P., Thorne, C., LeClercq, S., Mittoo, S., Grodzicky, T., Ligier, S., Mathieu, J.-P., Docherty, P., Kaminska, E., Jones, N., Robinson, D., Khalidi, N.A., Sutton, E., Masetto, D.A., Pope, J., Thombs, B.D., Baron, M., Hudson, M., Hagedoorn, M., Steele, R.J., Kwakkenbos, L., Rice, D.B., Levis, B., Arthritis Care and Research, 2016, 10.1002/acr.22802

Evaluating the Construct of Damage in Systemic Lupus Erythematosus, Ian N. Bruce, Asad Zoma, Daniel J. Wallace, Heather Waldhauser, Ronald F. van Vollenhoven, Evelyne Vinet, Murray Urowitz, Zahi Touma, Elisabet Svenungsson, Jorge Sanchez‐Guerrero, Guillermo Ruiz‐Irastorza, Juanita Romero‐Diaz, John A. Reynolds, Rosalind Ramsey‐Goldman, Anisur Rahman, Michelle Petri, Christine A. Peschken, Eric F. Morand, Anselm Mak, S. Sam Lim, Alexandra Legge, Chynace Lambalgen, Diane L. Kamen, Kenneth Kalunian, Soren Jacobsen, John G. Hanly, Ellen M. Ginzler, Rebecca Gilman, Bernardo A. Pons‐Estel, Guillermo J. Pons‐Estel, Jessica A. English, Nathalie Costedoat‐Chalumeau, Sang‐Cheol Bae, Graciela S. Alarcón, Anca Askanase, Cynthia Aranow, Susan Manzi, Alexandre E. Voskuyl, Marta Mosca, Paul R. Fortin, Laurent Arnaud, Megan R. W. Barber, Ann E. Clarke, David Isenberg, Hermine I. Brunner, Dafna D. Gladman, Sindhu R. Johnson, Arthritis Care & Research, 2023, 10.1002/acr.24849

Platelets disseminate extracellular vesicles in lymph in rheumatoid arthritis, Boilard, É., Martel, C., Fortin, P.R., Wolberg, A.S., Brisson, A.R., Provost, P., Gilbert, C., McKenzie, S.E., Côté, F., Lévesque, T., Benmoussa, A., Michel, S., Milasan, A., Tan, S., Miszta, A., Allaeys, I., Cloutier, N., Melki, I., Tessandier, N., Arteriosclerosis, Thrombosis, and Vascular Biology, 2020, 10.1161/ATVBAHA.119.313698

Breast cancer in systemic lupus, Clarke, A.E., Tessier-Cloutier, B., Raymer, P.C., St Pierre, Y., Hansen, J.E., Foulkes, W.D., Sturfeldt, G., Kamen, D., Aranow, C., Ruiz-Irastorza, G., Witte, T., Joseph, L., Bae, S.-C., Rahman, A., Isenberg, D., Yelin, E.H., Nived, O., Gordon, C., Hanly, J.G., Jacobsen, S., Peschken, C., Romero-Diaz, J., Ginzler, E., Fortin, P.F., Gladman, D.D., Urowitz, M.B., Petri, M., Ramsey-Goldman, R., Bernatsky, S., Lupus, 2017, 10.1177/0961203316664595

An assessment of disease flare in patients with systemic lupus erythematosus: A comparison of BILAG 2004 and the flare version of SELENA, Rahman, A., Gordon, C., Wallace, D.J., Urowitz, M., Sturfelt, G., Ramsey-Goldman, R., Petri, M., Nived, O., Merrill, J.T., Khamashta, M., Kalunian, K., Hanly, J.G., Inanc, M., Gladman, D.D., Ginzler, E.M., Fortin, P.R., Dooley, M.A., Bruce I.n., Aranow, C., Alarcón, G.S., D'Cruz, D., Allen, E., Farewell, V., Isenberg, D.A., Annals of the Rheumatic Diseases, 2011, 10.1136/ard.2010.132068

Economic Evaluation of Damage Accrual in an International Systemic Lupus Erythematosus Inception Cohort Using a Multistate Model Approach, Clarke, A.E., Buyon, J., Stoll, T., Farewell, V., Askanase, A., Jacobsen, S., Peschken, C.A., Kamen, D.L., Inanc, M., Kalunian, K.C., Lim, S.S., Ruiz-Irastorza, G., Ramos-Casals, M., van Vollenhoven, R.F., Zoma, A.A., Jönsen, A., Manzi, S., Nived, O., Alarcón, G.S., Mackay, M., Aranow, C., Khamashta, M.A., Ramsey-Goldman, R., Steinsson, K., Sanchez-Guerrero, J., Gladman, D.D., Fortin, P.R., Dooley, M.A., Bruce, I.N., Petri, M., Ginzler, E.M., Rahman, A., Isenberg, D.A., Merrill, J.T., Wallace, D.J., Bernatsky, S., Bae, S.-C., Gordon, C., Romero-Diaz, J., St. Pierre, Y., Urowitz, M.B., Su, L., Hanly, J.G., Barber, M.R.W., Arthritis Care and Research, 2020, 10.1002/acr.24092

Medication use in systemic lupus erythematosus (Journal of Rheumatology (2010) 38 (271-274)), Fortin, P.R., Peschken, C., Bernatsky, S., Journal of Rheumatology, 2012, 10.3899/jrheum.100414.C1

Spatial modelling of lupus incidence over 40 years with changes in census areas, Fortin, P., Al-Maini, M., Rue, H., Brown, P., Li, Y., Journal of the Royal Statistical Society. Series C: Applied Statistics, 2012, 10.1111/j.1467-9876.2011.01004.x

Vasculitides associated with malignancy, Fortin, P.R., Current Opinion in Rheumatology, 1996, 10.1097/00002281-199601000-00005

A study of manufacturer-supported trials of nonsteroidal anti- inflammatory drugs in the treatment of arthritis, Chalmers, T.C., Minaker, K.L., Felson, D.T., Fortin, P.R., Simms, R.W., Gurwitz, J.H., Rochon, P.A., Archives of Internal Medicine, 1994, 10.1001/archinte.154.2.157

Association of LY9 in UK and Canadian SLE families, Rioux, J.D., Wither, J., Greenwood, C.M.T., Terhorst, C., Hudson, T.J., Sharpe, A., Chad, L., Rhodes, B., Farwell, L., McKenzie, T., Lim, S., Cai, Y.-C., Montpetit, A., Fortin, P.R., Vyse, T.J., Graham, D.S.C., Genes and Immunity, 2008, 10.1038/sj.gene.6364453

Comparison of the responsiveness of lupus disease activity measures to changes in systemic lupus erythematosus activity relevant to patients and physicians, Fortin, P.R., Ferland, D., Abrahamowicz, M., Chang, E., Journal of Clinical Epidemiology, 2002, 10.1016/S0895-4356(01)00509-1

Early Mortality in a Multinational Systemic Sclerosis Inception Cohort, Zochling, J., Youssef, P., Walker, J., Stevens, W., Sahhar, J., Roddy, J., Proudman, S., Thorne, C., Sutton, E., Smith, D., Rodriguez-Reyna, T.S., Robinson, D., Pope, J., Mathieu, J.-P., Masetto, A., Markland, J., Ligier, S., LeClercq, S., Larché, M., Khalidi, N., Kaminska, E., Jones, N., Hudson, M., Gyger, G., Grodzicky, T., Fritzler, M., Fortin, P.R., Docherty, P., Cabral, A.R., Abu-Hakima, M., Nikpour, M., Proudman, S., Huq, M., Joven, B.E., Carmona, L., Tatibouet, S., Rabusa, C., Stevens, W., Carreira, P., Baron, M., Hudson, M., Hao, Y., Arthritis and Rheumatology, 2017, 10.1002/art.40027

Neuropsychiatric events in systemic lupus erythematosus: A longitudinal analysis of outcomes in an international inception cohort using a multistate model approach, Farewell, V., Askanase, A., Kamen, D.L., Peschken, C.A., Jacobsen, Sø., Kalunian, K.C., Inanc, M., Lim, S., Ruiz-Irastorza, G., MacKay, M., Aranow, C., Van Vollenhoven, R.F., Alarcón, G.S., Jönsen, A., Manzi, S., Ramsey-Goldman, R., Dooley, M.A., Ginzler, E.M., Petri, M., Bruce, I.N., Gladman, D.D., Fortin, P.R., Merrill, J.T., Rahman, A., Isenberg, D.A., Wallace, D.J., Clarke, A.E., Bernatsky, S., Sanchez-Guerrero, J., Romero-Diaz, J., Bae, S.-C., Gordon, C., Urowitz, M.B., Hanly, J.G., Annals of the Rheumatic Diseases, 2019, 10.1136/annrheumdis-2019-216150

Common variants in the NLRP3 region contribute to Crohn's disease susceptibility, Franchimont, D., Hudson, T.J., Vermeire, S., Rioux, J.D., Rutgeerts, P., Sarfati, M., Wither, J.E., Fortin, P.R., Langelier, D., Cohen, A., Gaudet, D., Bitton, A., Belaiche, J., Libioulle, C., Baba, N., Collette, C., Silverberg, M.S., Louis, E., Fortin, G., Lemire, M., Villani, A.-C., Nature Genetics, 2009, 10.1038/ng.285

Adaptation and validation of the rheumatoid arthritis quality of life scale for use in Canada, Fortin, P.R., Le Comte, M., McKenna, S., Whalley, D., Neville, C., Journal of Rheumatology, 2001

The prevalence and accuracy of self-reported history of 11 autoimmune diseases, Inman, R., Carette, S., Senecal, J.-L., Rich, E., Boire, G., Barr, S., Zummer, M., Hitchon, C., Peschken, C., Clarke, A., Smith, C.D., Hanly, J., Urowitz, M., Gladman, D., Pope, J., Greenwood, C.M.T., Hudson, T., Fortin, P.R., Bernatsky, S., Claudio, J.O., Mckenzie, T., Wither, J., Cooper, G.S., Journal of Rheumatology, 2008

A hot spot for systemic lupus erythematosus, but not for psoriatic arthritis, identified by spatial analysis suggests an interaction between ethnicity and place of residence, Fortin, P.R., Gladman, D.D., Su, J., Li, L., Lee, J.J.Y., Brown, P., Jeyalingam, T., Al-Maini, M., Arthritis and Rheumatism, 2013, 10.1002/art.37897

A comparison of health-related quality of life (HRQoL) across four systemic autoimmune rheumatic diseases (SARDs), Baron, M., Bernatsky, S., Wang, M., Pineau, C.A., Bykerk, V., Fortin, P.R., Vinet, E., Hudson, M., Greenfield, J., PLoS ONE, 2017, 10.1371/journal.pone.0189840

Assessment of the educational impact of an information leaflet on the knowledge of complications in systemic sclerosis,Évaluation de l'impact d'une brochure d'information sur la connaissance des complications dans la sclérodermie systémique, Michou, L., Fortin, P.R., Bessette, L., Brown, J.P., Beaudoin, C., Ikic, A., Revue du Rhumatisme (Edition Francaise), 2015, 10.1016/j.rhum.2015.04.001

Identification of a neutrophil-related gene expression signature that is enriched in adult systemic lupus erythematosus patients with active nephritis: Clinical/pathologic associations and etiologic mechanisms, Landolt-Marticorena, C., Boutros, P.C., Fortin, P.R., Scholey, J., Reich, H.N., Avila-Casado, C., Touma, Z., Bonilla, D., Chang, N.-H., Noamani, B., Prokopec, S.D., Wither, J.E., PLoS ONE, 2018, 10.1371/journal.pone.0196117

Predictors of Unsuccessful Hydroxychloroquine Tapering and Discontinuation: Can We Personalize Decision‐Making in Systemic Lupus Erythematosus Treatment?, Sasha Bernatsky, Michal Abrahamowicz, Paul R. Fortin, Ann E. Clarke, Christine A. Peschken, John G. Hanly, Evelyne Vinet, Christian A. Pineau, Celline C. Almeida‐Brasil, Arthritis Care & Research, 2022, 10.1002/acr.24548

Red blood cell-derived phosphatidylserine positive extracellular vesicles are associated with past thrombotic events in patients with systemic erythematous lupus, Sylvain G Bourgoin, Paul R Fortin, Eric Boilard, Chenqi Zhao, Anne-Claire Duchez, Anne-Sophie Julien, Stephan Hasse, Lupus Science & Medicine, 2022, 10.1136/lupus-2021-000605

Approaches for estimating minimal clinically important differences in systemic lupus erythematosus, Aviña-Zubieta, J.A., Fortin, P.R., Yazdany, J., Rai, S.K., Arthritis Research and Therapy, 2015, 10.1186/s13075-015-0658-6

25-hydroxyvitamin D and cardiovascular disease in patients with systemic lupus erythematosus: Data from a large international inception cohort, Ramsey-Goldman, R., Stoll, T., Van Vollenhoven, R., Font, J., Aranow, C., Petri, M., Kalunian, K., Dooley, M.A., Manzi, S., Steinsson, K., Sturfelt, G., Nived, O., Bruce, I., Khamashta, M., Ginzler, E., Wallace, D.J., Merrill, J., Rahman, A., Hanly, J.G., Isenberg, D., Bernatsky, S., Clarke, A., Gordon, C., Bae, S.-C., Fortin, P., Gladman, D., Urowitz, M., Dyer, A., Wu, P., Lertratanakul, A., Arthritis Care and Research, 2014, 10.1002/acr.22291

Underestimating the value of women: Assessing the indirect costs of women with systemic lupus erythematosus, Grodzicky, T., Esdaile, J.M., Choquette, D., Goulet, J.R., Sutcliffe, N., Fortin, P.R., Senecal, J.-L., Gordon, C., Isenberg, D.A., Manzi, S., Petri, M.A., St. Pierre, Y., Penrod, J., Clarke, A.E., Journal of Rheumatology, 2000

Serum albumin as a marker for disease activity in patients with systemic lupus erythematosus, Urowitz, M.B., Fortin, P.R., Gladman, D.D., Scholey, J., Bargman, J., Reich, H., Lou, W., Su, J., Aghdassi, E., Yip, J., Journal of Rheumatology, 2010, 10.3899/jrheum.091028

Glomerular filtration rate predicts arterial events in women with systemic lupus erythematosus, Fortin, P.R., Scholey, J., Urowitz, M.B., Gladman, D.D., Landolt-Marticorena, C., Lou, W., Su, J., Reich, H.N., Aghdassi, E., Zhang, W., Rheumatology, 2011, 10.1093/rheumatology/keq383

Validation of the social interaction anxiety scale in scleroderma: A scleroderma patientcentered intervention network cohort study, Persmann, J., Pepin, M.R., Levis, B., Fedoruk, C., Delisle, V.C., Wilcox, P., Varga, J., Thorne, C., Sutton, E., Steen, V., Spiera, R., Smith, D., Roux, S., Robinson, D., Masetto, A., Manning, J., Liang, P., Korman, B., Khalidi, N., Kafaja, S., Fernandes, A.J.D.B., Jones, N., Ikic, A., Hinchcliff, M., Herrick, A.L., Gyger, G., Gordon, J., Gill, A., Fortin, P., Dunne, J.V., Domsic, R., Denton, C., Dagenais, P., Chung, L., Carreira, P., Bruns, A., Boire, G., Bissonnette, L., Arsenault, G., Wong-Rieger, D., Albert, A., Welling, J., Suarez-Almazor, M.E., Steele, R.J., Schouffoer, A.A., Reyna, T.S.R., Portales, A., Pope, J., Nielsen, K., Marra, C., Leite, C., Larche, M., Kennedy, A.T., Johnson, S.R., Jang, Y., Impens, A., Hudson, M., Harel, D., Godard, D., Frech, T., Fortune, C., Fligelstone, K., Van Den Ende, C., Ells, C., El-Baalbaki, G., Maia, A.C., Boutron, I., Assassi, S., Wigley, F., Sauve, M., Riggs, R., Poiraudeau, S., Nielson, W.R., Mouthon, L., Mayes, M.D., Van Den Hoogen, F., Furst, D., Bartlett, S.J., Baron, M., Malcarne, V.L., Thombs, B.D., Roesch, S., Gottesman, K., Jewett, L.R., Fox, R.S., Mills, S.D., Carrier, M.-E., Kwakkenbos, L., Gholizadeh, S., Journal of Scleroderma and Related Disorders, 2018, 10.5301/jsrd.5000264

Alterations in circulating fatty acid composition in patients with systemic lupus erythematosus: A pilot study, Fortin, P.R., Urowitz, M.B., Gladman, D.D., Clarke, S., Hillyer, L.M., Morrison, S., Ma, D.W.L., Aghdassi, E., Journal of Parenteral and Enteral Nutrition, 2011, 10.1177/0148607110386378

Construction of a frailty index as a novel health measure in systemic lupus erythematosus, Hanly, J.G., Askanase, A., Peschken, C.A., Jacobsen, S., Kalunian, K.C., Kamen, D.L., Ramos-Casals, M., Nived, O., Jonsen, A., Van Vollenhoven, R.F., Inanc, M., Lim, S.S., Ruiz-Irastorza, G., MacKay, M., Aranow, C., Zoma, A.A., Manzi, S., Ramsey-Goldman, R., Dooley, M.A., Khamashta, M.A., Petri, M., Alarcon, G.S., Rahman, A., Isenberg, D.A., Bruce, I.N., Urowitz, M.B., Fortin, P., Gladman, D.D., Ginzler, E.M., Merrill, J.T., Clarke, A.E., Bernatsky, S., Wallace, D.J., Sanchez-Guerrero, J., Romero-Diaz, J., Gordon, C., Bae, S.-C., Andreou, P., Rockwood, K., Legge, A., Kirkland, S., Journal of Rheumatology, 2020, 10.3899/jrheum.181338

Reporting of Age Data in Clinical Trials of Arthritis: Deficiencies and Solutions, Chalmers, T.C., Minaker, K.L., Dear, K.B.G., Fortin, P.R., Rochon, P.A., Archives of Internal Medicine, 1993, 10.1001/archinte.1993.00410020091008

The importance of patient expectations in predicting functional outcomes after total joint arthroplasty, Katz, J.N., Fossel, A.H., Fortin, P.R., Daltroy, L.H., Cook, E.F., Liang, M.H., Mahomed, N.N., Journal of Rheumatology, 2002

Reply, Lou, W., Jung, H., Fortin, P.R., Arthritis and Rheumatism, 2010, 10.1002/art.27620

Quality assurance in Canada: Does insurance affect assurance?, Fortin, P.R., Journal of Rheumatology, 1992

Preferences for COVID-19 Vaccination in People With Chronic Immune-Mediated Inflammatory Diseases, Gilaad G. Kaplan, Dawn P. Richards, Laurie Proulx, Nick Bansback, Mark Harrison, Claire E.H. Barber, Megan Thomas, Todd Wilson, Dianne Mosher, Ann E. Clarke, Sasha Bernatsky, Paul R. Fortin, Carol Hitchon, Ines Colmegna, Glen S. Hazlewood, The Journal of Rheumatology, 2023, 10.3899/jrheum.220697

Cardiovascular events prior to or early after diagnosis of systemic lupus erythematosus in the systemic lupus international collaborating clinics cohort, Stoll, T., Askanase, A., Peschken, C., Jacobsen, S., Kamen, D.L., Ramos-Casals, M., Van Vollenhoven, R., Inanç, M., Kalunian, K.C., Lim, S., Ruiz-Irastorza, G., Zoma, A., Steinsson, K., Nived, O., Sturfelt, G., Ramsey-Goldman, R., Manzi, S., Dooley, M., Aranow, C., Khamashta, M., Bruce, I.N., Petri, M., Fessler, B.F., Alarcón, G.S., Ginzler, E., Merrill, J., Rahman, A., Isenberg, D., Wallace, D.J., Hanly, J.G., Gordon, C., Bernatsky, S., Clarke, A., Sanchez-Guerrero, J., Fortin, P.R., Bae, S.C., Romero-Diaz, J., Su, J., Anderson, N.M., Gladman, D.D., Urowitz, M.B., Lupus Science and Medicine, 2016, 10.1136/lupus-2015-000143

Soluble urokinase plasminogen activator receptor (suPAR) levels predict damage accrual in patients with recent-onset systemic lupus erythematosus, Sjöwall, C., Wetterö, J., Bruce, I.N., Stoll, T., Askanase, A., Peschken, C.A., Jacobsen, S., Kamen, D.L., Ramos-Casals, M., van Vollenhoven, R.F., Inanc, M., Kalunian, K.C., Lim, S.S., Ruiz-Irastorza, G., Zoma, A.A., Steinsson, K., Nived, O., Ramsey-Goldman, R., Manzi, S., Dooley, M.A., Mackay, M., Aranow, C., Khamashta, M., Petri, M., Chatham, W.W., Alarcón, G.S., Ginzler, E., Merrill, J.T., Rahman, A., Isenberg, D.A., Wallace, D.J., Hanly, J.G., Gordon, C., Bernatsky, S., Clarke, A.E., Sanchez-Guerrero, J., Fortin, P.R., Bae, S.-C., Romero-Diaz, J., Gladman, D.D., Urowitz, M.B., Jönsen, A., Padyukov, L., Dahle, C., Wirestam, L., Enocsson, H., Journal of Autoimmunity, 2020, 10.1016/j.jaut.2019.102340

Counterbalancing patient demands with evidence: Results from a Pan-Canadian randomized clinical trial of brief supportive-expressive group psychotherapy for women with systemic lupus erythematosus, Clarke, A.E., St-Pierre, Y., Gladman, D., Cividino, A., Smith, D., Rich, E., Choquette, D., Goulet, J.-R., Senécal, J.-L., Zummer, M., Beaulieu, A., Esdaile, J.M., Ensworth, S., Barr, S., Edworthy, S., Fortin, P.R., Joseph, L., Da Costa, D., Dobkin, P.L., Annals of Behavioral Medicine, 2002, 10.1207/S15324796ABM2402_05

The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: Results from the APS ACTION cohort, Andrade, D., Bertolaccini, M.L., Mackie, I., Efthymiou, M., Barbhaiya, M., Sevim, E., Banzato, A., Borges Gualhardo Vendramini, M., Rossi Gandara, A.P., Lopez-Pedrera, R., Gonzalez, E., Willis, R., Atsumi, T., Knight, J.S., Rodriguez-Pinto, I., Rodriguez, E., Petri, M., Andreoli, L., Fortin, P.R., Branch, D.W., Ramires de Jesús, G., Cohen, H., Belmont, H.M., Ji, L., Meroni, P., Ugarte, A., Tektonidou, M.G., Pengo, V., Erkan, D., Sciascia, S., Radin, M., Seminars in Arthritis and Rheumatism, 2019, 10.1016/j.semarthrit.2019.04.009

Work factors are associated with workplace activity limitations in systemic lupus erythematosus, Fortin, P.R., Su, J., Beaton, D.E., Gignac, M.A., Dhanhani, A.M., Rheumatology (United Kingdom), 2014, 10.1093/rheumatology/keu242

Comprehensive radiographic evaluation of diffuse idiopathic skeletal hyperostosis: Development and interrater reliability of a scoring system, Esdaile, J.M., Joseph, L., Fortin, P.R., Chhem, R.K., Mata, S., Seminars in Arthritis and Rheumatism, 1998, 10.1016/S0049-0172(98)80041-3

Health-related quality of life (HRQoL) in idiopathic inflammatory myopathy: A systematic review, Fritzler, M., Fortin, P.R., Gyger, G., Vinet, E., O'Ferrall, E., Genge, A., Baron, M., Hudson, M., Wojcik, S., Regardt, M., Leclair, V., PLoS ONE, 2016, 10.1371/journal.pone.0160753

Are indirect utility measures reliable and responsive in rheumatoid arthritis patients?, Anis, A.H., Fortin, P.R., Brazier, J.E., Esdaile, J.M., Abrahamowicz, M., Kopec, J.A., Guh, D., Rashidi, A.A., Marra, C.A., Quality of Life Research, 2005, 10.1007/s11136-004-6012-0

Vasculitis and malignancy, Fortin, P.R., Inflammatory Diseases of Blood Vessels, 2000, 10.1201/b14012

Fine particulate air pollution and systemic autoimmune rheumatic disease in two Canadian provinces, Joseph, L., Bélisle, P., Edworthy, S., van Donkelaar, A., Fortin, P.R., Clarke, A.E., Hudson, M., Martin, R.V., Brand, A., Svenson, L.W., Barnabe, C., Smargiassi, A., Bernatsky, S., Environmental Research, 2016, 10.1016/j.envres.2015.12.021

Atherosclerotic vascular events in a multinational inception cohort of systemic lupus erythematosus, Maddison, P., Petri, M., Stoll, T., Aranow, C., Van Vollenhoven, R.F., Ramos, M., Kalunian, K., Zoma, A., Dooley, M.A., Ramsey-Goldman, R., Manzi, S., Steinsson, K., Bruce, I.N., Sturfelt, G., Nived, O., Khamashta, M., Ginzler, E., Merrill, J.T., Alarcón, G.S., Rahman, A., Isenberg, D., Wallace, D.J., Hanly, J.G., Fortin, P.R., Bernatsky, S., Clarke, A., Gordon, C., Sanchez-Guerrero, J., Bae, S.C., Ibañez, D., Gladman, D., Urowitz, M.B., Arthritis Care and Research, 2010, 10.1002/acr.20122

An international perspective on the well being and health care costs for patients with systemic lupus erythematosus, Esdaile, J.M., Ho, V., Danoff, D.S., Grodzicky, T., Choquette, D., Goulet, J.R., Sutcliffe, N., Fortin, P.R., Penrod, J., Joseph, L., St. Pierre, Y., Senecal, J.-L., Gordon, C., Isenberg, D.A., Manzi, S., Petri, M.A., Clarke, A.E., Journal of Rheumatology, 1999

The Impact of Systemic Lupus Erythematosus on the Clinical Phenotype of Antiphospholipid Antibody–Positive Patients: Results From the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Clinical Database and Repository, Tektonidou, M.G., Zuily, S., Willis, R., Atsumi, T., Knight, J.S., Pons-Estel, G.J., Rodriguez, E., Petri, M., Fortin, P.R., Belmont, H.M., Tincani, A., de Jesus, G.R., Branch, D.W., Efthymiou, M., Ji, L., Gerosa, M., Ugarte, A., Pengo, V., Banzato, A., Rosa, R., Nascimento, I., Andrade, D., Barbhaiya, M., Erkan, D., Unlu, O., Arthritis Care and Research, 2019, 10.1002/acr.23584

Infections in the lupus patient: Perspectives on prevention, Fortin, P.R., Gold, W.L., Barber, C., Current Opinion in Rheumatology, 2011, 10.1097/BOR.0b013e3283476cd8

Sharing ongoing care with primary care physicians opens up opportunity for timelier and earlier care by rheumatologists for patients with new inflammatory polyarthritis, Michou, L., Fortin, P.R., Bessette, L., Julien, A.-S., Nguyen, P., Journal of Rheumatology, 2018, 10.3899/jrheum.170494

The American College of Rheumatology response criteria for systemic lupus erythematosus clinical trials: Measures of overall disease activity, Strand, V., St.Clair, E.W., Smolen, J., Schur, P., Roberts Jr., N., Phillips, C., Petri, M., Mosca, M., Moore, A., Mikdashi, J., Meyrier, A., McCune, J., Manzi, S., Lockshin, M., Koike, T., Khamashta, M., Kalden, J., Johnson, K., Iking-Konert, C., Isenberg, D., Illei, G., Gordon, C., Gladman, D., Fischer-Betz, R., Finckh, A., Esdaile, J.M., De Pablo, P., Crofford, L., Costenbader, K., Chehab, G., Buyon, J., Bischoff-Ferrari, H., Benito-Garcia, E., Balow, J., Bombardieri, S., Alarcón, G.S., Abrahamowicz, M., Schneider, M., Fortin, P., Liang, M.H., Arthritis and Rheumatism, 2004, 10.1002/art.20628

Fluctuation of Anti–Domain 1 and Anti–β2‐Glycoprotein I Antibody Titers Over Time in Patients With Persistently Positive Antiphospholipid Antibodies, Maria Laura Bertolaccini, Doruk Erkan, Hannah Cohen, Maria Efthymiou, Rohan Willis, Jason S. Knight, Ricard Cervera, Michelle A. Petri, Laura Andreoli, D. Ware Branch, Paul Fortin, Maria Gerosa, H. Michael Belmont, Guillermo Ruiz‐Irastorza, Vittorio Pengo, Maria Tektonidou, Danieli Andrade, Francesca Pregnolato, Cecilia B. Chighizola, Arthritis & Rheumatology, 2023, 10.1002/art.42459

The needs of persons with lupus and health care providers: A qualitative study aimed toward the development of the Lupus Interactive Navigator™, Fortin, P.R., Eng, D., Pineau, C.A., Aviña-Zubieta, J.A., Rochon, M., Mill, C., Costa, D.D., Neville, C., Lupus, 2014, 10.1177/0961203313517154

Systemic lupus international collaborative clinics: Development of a damage index in systemic lupus erythematosus, Symmons, D., Sturfelt, G., Snaith, M., Sanchez-Guerrero, J., Richter, M., Petri, M., Nived, O., Verrier Jones, J., Isenberg, D., Hay, E., Hanly, J., Bombardieri, S., Bacon, P., Urowitz, M., Liang, M., Fortin, P., Goldsmith, C., Ginzler, E., Gladman, D., Journal of Rheumatology, 1992

The relationship between disease activity and expert physician's decision to start major treatment in active systemic lupus erythematosus: A decision aid for development of entry criteria for clinical trials, Liang, M.H., Neville, C., Nayak, V., Du Berger, R., Fortin, P.R., Abrahamowicz, M., Journal of Rheumatology, 1998

Thrombosis and inflammation: A question in need of an answer, Fortin, P.R., Landolt-Marticorena, C., Bobba, R., Journal of Rheumatology, 2005

Group psychotherapy reduces illness intrusiveness in systemic lupus erythematosus, Devins, G.M., Gladman, D., Cividino, A., Smith, D., Rich, E., Choquette, D., Goulet, J.-R., Senécal, J.-L., Zummer, M., Beaulieu, A., Esdaile, J.M., Ensworth, S., Fortin, P.R., Barr, S., Dritsa, M., Da Costa, D., Clarke, A.E., Dobkin, P.L., Edworthy, S.M., Journal of Rheumatology, 2003

Transitioning to employment with a rheumatic disease: The role of independence, overprotection, and social support, Gignac, M.A.M., Mosher, D.P., Tucker, L.B., Rosenberg, A.M., Shiff, N.J., Fortin, P.R., Beaton, D., Badley, E., Jetha, A., Journal of Rheumatology, 2014, 10.3899/jrheum.140419

Methodologic issues in the validation of putative biomarkers and surrogate endpoints in treatment evaluation for systemic lupus erythematosus, Abrahamowicz, M., Gupta, S., Buyon, J., Mittleman, B., Manzi, S., Illei, G.G., Fortin, P.R., Ward, M., Dore, B.T., Costenbader, K., Simard, J.F., Liang, M.H., Endocrine, Metabolic and Immune Disorders - Drug Targets, 2009, 10.2174/187153009787582388

The systemic lupus erythematosus tri-nation study: Cumulative indirect costs, Clarke, A.E., Esdaile, J.M., Grodzicky, T., Choquette, D., Sutcliffe, N., Goulet, J.-R., Fortin, P.R., Pineau, C., St. Pierre, Y., Joseph, L., Penrod, J.R., Gordon, C., Senégal, J.-L., Isenberg, D.A., Petri, M., Manzi, S., Panopalis, P., Arthritis Care and Research, 2007, 10.1002/art.22470

A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome, Kovacs, M.J., Gent, M., Wilson, S., Yacura, W., Costantini, L., Green, D., Forgie, M., Geerts, W., Clarke, A., Kearon, C., Anderson, D., Fortin, P., Laskin, C., Douketis, J., Hirsh, J., Denburg, J., Julian, J., Ginsberg, J.S., Crowther, M.A., New England Journal of Medicine, 2003, 10.1056/NEJMoa035241

Barriers to healthcare in a multiethnic cohort of systemic lupus erythematosus (SLE) patients: Patient and physician perceptions, Peschken, C., Hudson, M., Chedéville, G., Arbillaga, H., Ramsey, S., Huber, A., Albert, L., Tucker, L., Petty, R., Smith, C.D., Fortin, P., Zummer, M., Cooper, G., Silverman, E., Lalani, S., Pope, J., Law, G., Clinical Medicine: Arthritis and Musculoskeletal Disorders, 2009, 10.4137/cmamd.s2136

Relationship between calcium channel blockers and skin fibrosis in patients with systemic sclerosis, Fritzler, M., Fortin, P.R., Thorne, C., Smith, D., Rodriguez-Reyna, T.S., Robinson, D., Sutton, E., Masetto, A., Khalidi, N., Pope, J., Larché, M., Gyger, G., Hudson, M., Larché, M., Baron, M., Lorenzi, S., Fritzler, M.J., Hudson, M., Thabane, L., Cheng, J., Adachi, J.D., Li, G., Clinical and Experimental Rheumatology, 2017

Short-term outcome of neuropsychiatric events in systemic lupus erythematosus upon enrollment into an international inception cohort study, Farewell, V., Thompson, K., Qiufen Qi, K., Douglas, J., Kalunian, K., Ramsey-Goldman, R., Sturfelt, G., Nived, O., Ginzler, E., Aranow, C., Van Vollenhoven, R., Font, J., Zoma, A., Khamashta, M., Manzi, S., Bruce, I.N., Petri, M., Steinsson, K., Gladman, D., Fortin, P.R., Dooley, M.A., Bernatsky, S., Clarke, A., Merrill, J.T., Alarcón, G.S., Isenberg, D., Wallace, D.J., Gordon, C., Bae, S.C., Sanchez-Guerrero, J., Su, L., Urowitz, M.B., Hanly, J.G., Arthritis Care and Research, 2008, 10.1002/art.23566

Longitudinal evolution of risk of coronary heart disease in systemic lupus erythematosus, Esdaile, J.M., Pineau, C.A., Neville, C., Pilote, L., Abrahamowicz, M., Fortin, P.R., Karp, I., Journal of Rheumatology, 2012, 10.3899/jrheum.111127

The early protective effect of hydroxychloroquine on the risk of cumulative damage in patients with systemic lupus erythematosus, Fortin, P.R., Urowitz, M.B., Gladman, D.D., Lou, W., Su, J., Akhavan, P.S., Journal of Rheumatology, 2013, 10.3899/jrheum.120572

Valuing a hypothetical cure for rheumatoid arthritis using the contingent valuation methodology: The patient perspective, Penrod, J.R., Donaldson, C., Menard, H.A., Fortin, P.R., Panaritis, T., St-Pierre, Y., Adam, V., Guillemin, F., Clarke, A.E., Fautrel, B., Journal of Rheumatology, 2005

Immunosuppressive treatment in diffuse cutaneous systemic sclerosis is associated with an improved composite response index (CRISS), Fritzler, M.J., Fortin, P.R., Ikic, A., Thorne, C., Smith, D., Maltez, N., Rodriguez-Reyna, T.S., Robinson, D., Sutton, E., Masetto, A., Khalidi, N.A., Larché, M.J., Gyger, G., Hudson, M., Baron, M., Baron, M., Pope, J.E., Wang, M., Hudson, M., Zheng, B., Arthritis Research and Therapy, 2020, 10.1186/s13075-020-02220-0

A functional marked point process model for lupus data, Fortin, P., Abrahamowicz, M., Ramsay, J.O., Fok, C.C.T., Canadian Journal of Statistics, 2012, 10.1002/cjs.11136

Recent corticosteroid use and recent disease activity: Independent determinants of coronary heart disease risk factors in systemic lupus erythematosus?, Esdaile, J.M., Pineau, C.A., Pilote, L., Neville, C., Fortin, P.R., Abrahamowicz, M., Karp, I., Arthritis Care and Research, 2008, 10.1002/art.23352

Osteoporosis in systemic lupus erythematosus: Factors associated with referral for bone mineral density studies, prevalence of osteoporosis and factors associated with reduced bone density, Gladman, D.D., Ibanez, D., Fortin, P.J., Urowitz, M.B., Pineau, C.A., Lupus, 2004, 10.1191/0961203303lu1036oa

Increased expression of B cell activation factor supports the abnormal expansion of transitional B Cells in systemic lupus erythematosus, Wither, J., Fortin, P.R., Urowitz, M.B., Gladman, D.D., Scholey, J., Herzenberg, A., Reich, H., Wither, R., Landolt-Marticorena, C., Journal of Rheumatology, 2011, 10.3899/jrheum.100214

Association between serum total cholesterol level and renal outcome in systemic lupus erythematosus, Fortin, P.R., Gladman, D., Urowitz, M., Greenwood, C., Lim, S., Tisseverasinghe, A., Arthritis and Rheumatism, 2006, 10.1002/art.21929

Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: An international inception cohort study, Farewell, V., Thompson, K., Douglas, J., Kalunian, K., Ramsey-Goldman, R., Nived, O., Sturfelt, G., Font, J., Van Vollenhoven, R., Ginzler, E., Aranow, C., Zoma, A., Khamashta, M., Manzi, S., Bruce, I., Steinsson, K., Fortin, P.R., Gladman, D., Dooley, M.A., Petri, M., Merrill, J.T., Bernatsky, S., Clarke, A., Alarcón, G.S., Isenberg, D., Wallace, D.J., Gordon, C., Bae, S.C., Sanchez-Guerrero, J., Urowitz, M.B., Hanly, J.G., Arthritis and Rheumatism, 2007, 10.1002/art.22305

Small changes in outpatient lupus activity are better detected by clinical instruments than by laboratory tests, Danoff, D., Abrahamowicz, M., Fortin, P.R., Journal of Rheumatology, 1995

Malignancy prevalence in the first-degree relatives of persons with systemic lupus erythematous: A pilot study [1], Fortin, P.R., Boire, G., Rich, E., Peschken, C., Smith, C.D., Hanly, J.G., Pope, J., Clarke, A., Bernatsky, S., Lupus, 2006, 10.1177/0961203306072424

Lack of association between the interferon-α signature and longitudinal changes in disease activity in systemic lupus erythematosus, Wither, J., Fortin, P.R., Urowitz, M., Gladman, D.D., Su, J., Unnithan, T., Ferguson, C., Lubovich, A., Bonventi, G., Landolt-Marticorena, C., Annals of the Rheumatic Diseases, 2009, 10.1136/ard.2008.093146

SF-36 summary and subscale scores are reliable outcomes of neuropsychiatric events in systemic lupus erythematosus, Farewell, V., Kalunian, K., Zoma, A., Ramos-Casals, M., Van Vollenhoven, R., Aranow, C., Dooley, M.A., Ramsey-Goldman, R., Sturfelt, G., Nived, O., Manzi, S., Petri, M., Fessler, B., Alarcón, G.S., Khamashta, M., Steinsson, K., Bruce, I.N., Gladman, D.D., Fortin, P.R., Merrill, J.T., Romero-Diaz, J., Sanchez-Guerrero, J., Rahman, A., Isenberg, D., Vasudevan, A., Bernatsky, S., Clarke, A., Wallace, D.J., Gordon, C., Bae, S.C., Jackson, D., Urowitz, M.B., Hanly, J.G., Annals of the Rheumatic Diseases, 2011, 10.1136/ard.2010.138792

Connective tissue diseases: Mitochondria drive NETosis and inflammation in SLE, Fortin, P.R., Boilard, E., Nature Reviews Rheumatology, 2016, 10.1038/nrrheum.2016.24

Anti-mitochondrial autoantibodies in systemic lupus erythematosus and their association with disease manifestations, Boilard, E., Fortin, P.R., Rauch, J., Dieudé, M., Hébert, M.-J., Belleannée, C., Tremblay, M.-È., Hajj, H.E., Pelletier, M., Wagner, É., Eder, L., Melki, I., Cloutier, N., Benk-Fortin, H., Rollet-Labelle, E., Lévesque, T., Allaeys, I., Marcoux, G., Julien, A.-S., Loignon, R.-C., Becker, Y., Scientific Reports, 2019, 10.1038/s41598-019-40900-3

SARS-CoV-2 rapidly evolves lineage-specific phenotypic differences when passaged repeatedly in immune-naïve mice, Louis Flamand, Jiannis Ragoussis, Shu-Huang Chen, Anne-Marie Roy, Sally Lee, Melissa Zwaig, Haig Hugo Vrej Djambazian, Jose Hector Galvez, Jose Avila Cervantes, Ju-Ling Liu, Paul Fortin, Émile Lacasse, Ana Claudia dos Santos Pereira Andrade, Leslie Gudimard, Isabelle Dubuc, Annie Gravel, Julian Daniel Sunday Willett, Communications Biology, 2024, 10.1038/s42003-024-05878-3

Validation of a meta-analysis: The effects of fish oil in rheumatoid arthritis, Sperling, R.I., Chalmers, T.C., Beckett, L.A., Wright, E.A., Liang, M.H., Lew, R.A., Fortin, P.R., Journal of Clinical Epidemiology, 1995, 10.1016/0895-4356(95)00028-3

Mood disorders in systemic lupus erythematosus: Results from an international inception cohort study, Farewell, V., Thompson, K., Theriault, C., Askanase, A., Jacobsen, S., Peschken, C.A., Kamen, D.L., Inanc, M., Kalunian, K.C., Lim, S.S., Ruiz-Irastorza, G., Ramos-Casals, M., Van Vollenhoven, R.F., Zoma, A.A., Sturfelt, G.K., Nived, O., Manzi, S., Fessler, B.J., Alarcón, G.S., Aranow, C., Khamashta, M.A., Ramsey-Goldman, R., Steinsson, K., Sanchez-Guerrero, J., Gladman, D.D., Fortin, P., Dooley, M.A., Bruce, I.N., Petri, M., Ginzler, E.M., Rahman, A., Isenberg, D.A., Merrill, J.T., Wallace, D.J., Clarke, A.E., Bernatsky, S., Bae, S.-C., Gordon, C., Romero-Diaz, J., Urowitz, M.B., Su, L., Hanly, J.G., Arthritis and Rheumatology, 2015, 10.1002/art.39111

Response criteria for clinical trials in systemic lupus erythematosus, Fortin, P.R., Liang, M.H., Lupus, 1995, 10.1177/096120339500400502

Healthcare cost and loss of productivity in a Canadian population of patients with and without lupus nephritis, Fortin, P.R., Wither, J.E., Peschken, C., Pope, J.E., Herzenberg, A., Scholey, J., Reich, H., Su, J., Landolt-Marticorena, C., Peeva, V., Morrison, S., Clarke, A.E., St.-Pierre, Y., Zhang, W., Aghdassi, E., Journal of Rheumatology, 2011, 10.3899/jrheum.100482

Systemic Lupus Erythematosus Women with Lupus Nephritis in Pregnancy Therapeutic Challenge (SWITCH): The Systemic Lupus International Collaborating Clinics experience, Évelyne Vinet, Sasha Bernatsky, Daniel J Wallace, Murray Urowitz, Jorge Sanchez-Guerrero, Anisur Rahman, Michelle Petri, Marta Mosca, Anselm Mak, David Alan Isenberg, Murat Inanç, John G Hanly, Rosalind Ramsey-Goldman, Dafna D Gladman, Paul R Fortin, Nathalie Costedoat-Chalumeau, Ann Elaine Clarke, Jill P Buyon, Sang-Cheol Bae, Anca Askanase, Arielle Mendel, Joo-Young E Lee, Annals of the Rheumatic Diseases, 2023, 10.1136/ard-2023-224197

Prevalence and risk factors for liver biochemical abnormalities in Canadian patients with systemic lupus erythematosus, Fortin, P.R., Urowitz, M.B., Gladman, D.D., Hirschfield, G.M., Mosko, J., Su, J., Aghdassi, E., Huang, D., Journal of Rheumatology, 2012, 10.3899/jrheum.110310

American college of rheumatology criteria at inception, and accrual over 5 years in the slicc inception cohort, Stoll, T., Aranow, C., Ramos-Casals, M., Van Vollenhoven, R., Manzi, S., Khamashta, M., Zoma, A., Ramsey-Goldman, R., Steinsson, K., Fessler, B., Alarcón, G.S., Dooley, M.A., Sturfelt, G., Nived, O., Merrill, J.T., Bruce, I.N., Petri, M., Ginzler, E., Wallace, D.J., Rahman, A., Isenberg, D., Hanly, J.G., Fortin, P.R., Bernatsky, S., Clarke, A.E., Bae, S.-C., Gordon, C., Romero-Diaz, J., Sanchez-Guerrero, J., Ibañez, D., Gladman, D.D., Urowitz, M.B., Journal of Rheumatology, 2014, 10.3899/jrheum.130704

SARS-CoV-2 evolution in the absence of selective immune pressures, results in antibody resistance, interferon suppression and phenotypic differences by lineage, Louis Flamand, Jiannis Ragoussis, Sally Lee, Shu-Huang Chen, Anne-Marie Roy, Melissa Zwaig, Haig Hugo Vrej Djambazian, Jose Hector Galvez, Jose Avila Cervantes, Ju-Ling Liu, Paul Fortin, Émile Lacasse, Ana Claudia dos Santos Pereira Andrade, Leslie Gudimard, Isabelle Dubuc, Annie Gravel, Julian Daniel Sunday Willett, 2023, 10.1101/2023.01.16.523994

Work disability in systemic lupus erythematosus, Fortin, P.R., Jiandong, S.U., Gignac, M.A.M., Dhanhani, A.M.A.L., Arthritis Care and Research, 2009, 10.1002/art.24347

A comparison between childhood and adult onset systemic lupus erythematosus adjusted for ethnicity from the 1000 Canadian Faces of Lupus Cohort, Pope, J.E., Peschken, C., Chedeville, G., Huber, A.M., Fortin, P., Hudson, M., Zummer, M., Arbillaga, H., Petty, R., Smith, C.D., Tucker, L., Pineau, C., Bernatsky, S., Hitchon, C., Silverman, E.D., Levy, D.M., Kim, H., Rheumatology (United Kingdom), 2019, 10.1093/rheumatology/kez006

Osteopontin and disease activity in patients with recent-onset systemic Lupus Erythematosus: Results from the SLICC Inception Cohort, Sjöwall, C., Wetterö, J., Bruce, I.N., Stoll, T., Askanase, A., Peschken, C., Jacobsen, S., Kamen, D.L., Ramos-Casals, M., Van Vollenhoven, R., Inanc, M., Kalunian, K., Lim, S., Ruiz-Irastorza, G., Zoma, A., Steinsson, K., Nived, O., Ramsey-Goldman, R., Manzi, S., Dooley, M.A., MacKay, M., Aranow, C., Khamashta, M., Petri, M., Chatham, W.W., Alarcón, G.S., Ginzler, E., Merrill, J., Rahman, A., Isenberg, D.A., Wallace, D., Hanly, J.G., Gordon, C., Clarke, A.E., Bernatsky, S., Sanchez-Guerrero, J., Fortin, P.R., Bae, S.-C., Romero-DIaz, J., Gladman, D.D., Urowitz, M.B., Jönsen, A., Padyukov, L., Skogh, T., Enocsson, H., Wirestam, L., Journal of Rheumatology, 2019, 10.3899/jrheum.180713

2013 american college of rheumatology/european league against rheumatism classification criteria for systemic sclerosis outperform the 1980 criteria: Data from the canadian scleroderma research group, Baron, M., Larché, M., Fortin, P.R., Smith, D., Gyger, G., Thorne, C., Leclercq, S., Grodzicky, T., Ligier, S., Mathieu, J.-P., Sutton, E., Masetto, A., Kaminska, E., Docherty, P., Khalidi, N., Jones, N., Robinson, D., Markland, J., Tatibouet, S., Pope, J., Fritzler, M., Hudson, M., Alhajeri, H., Arthritis Care and Research, 2015, 10.1002/acr.22451

Development and initial validation of a self-assessed lupus organ damage instrument, Wolfe, F., Alarcón, G.S., Michaud, K., Liu, J., Sanchez, M.L., Fortin, P.R., Chakravarty, E., Katz, R.S., Shaver, T.S., Hanly, J.G., Navarro, I., Fraser, P., Schur, P., Massarotti, E., Coblyn, J., Bermas, B., Turner-Stokes, T., Karlson, E.W., Manzi, S., Elliott, J., Petri, M., Perez-Rodriguez, M.T., Ruiz-Garcia, S., Khamashta, M., Costenbader, K.H., Arthritis Care and Research, 2010, 10.1002/acr.20193

Changes in quality of life in the first 5 years of disease in a multicenter cohort of patients with systemic lupus erythematosus, Stoll, T., Romero Diaz, J., Aranow, C., Van Vollenhoven, R., Kalunian, K., Maddison, P., Zoma, A., Ramsey-Goldman, R., Nived, O., Sturfelt, G., Manzi, S., Bruce, I.N., Dooley, M., Petri, M., Steinsson, K., Khamashta, M., Fessler, B., Alarcõn, G.S., Ginzler, E., Merrill, J., Rahman, A., Isenberg, D., Wallace, D.J., Hanly, J.G., Bernatsky, S., Clarke, A., Fortin, P.R., Gordon, C., Bae, S.C., Sanchez-Guerrero, J., Ibañez, D., Gladman, D.D., Urowitz, M., Arthritis Care and Research, 2014, 10.1002/acr.22299

Cerebrovascular Events in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study, Farewell, V., Theriault, C., Askanase, A., Kamen, D.L., Peschken, C.A., Jacobsen, S., Kalunian, K.C., Inanc, M., Lim, S.S., Ramos-Casals, M., Ruiz-Irastorza, G., Mackay, M., Aranow, C., van Vollenhoven, R.F., Chatham, W., Alarcón, G.S., Khamashta, M.A., Jonsen, A., Nived, O., Manzi, S., Zoma, A.A., Ramsey-Goldman, R., Steinsson, K., Dooley, M.A., Ginzler, E.M., Petri, M., Bruce, I.N., Gladman, D.D., Fortin, P., Merrill, J.T., Rahman, A., Isenberg, D.A., Wallace, D.J., Clarke, A.E., Bernatsky, S., Sanchez-Guerrero, J., Romero-Diaz, J., Bae, S.-C., Gordon, C., Urowitz, M.B., Su, L., Li, Q., Hanly, J.G., Arthritis Care and Research, 2018, 10.1002/acr.23509

A Longitudinal Analysis of Outcomes of Lupus Nephritis in an International Inception Cohort Using a Multistate Model Approach, Farewell, V., Theriault, C., Askanase, A., Jacobsen, S., Peschken, C.A., Kamen, D.L., Inanc, M., Kalunian, K.C., Lim, S.S., Ruiz-Irastorza, G., Ramos-Casals, M., van Vollenhoven, R.F., Zoma, A.A., Sturfelt, G.K., Nived, O., Manzi, S., Fessler, B.J., Alarcón, G.S., Aranow, C., Khamashta, M.A., Ramsey-Goldman, R., Steinsson, K., Sanchez-Guerrero, J., Gladman, D.D., Fortin, P., Dooley, M.A., Bruce, I.N., Petri, M., Ginzler, E.M., Rahman, A., Isenberg, D.A., Merrill, J.T., Wallace, D.J., Clarke, A.E., Bernatsky, S., Bae, S.-C., Gordon, C., Romero-Diaz, J., Urowitz, M.B., Su, L., Hanly, J.G., Arthritis and Rheumatology, 2016, 10.1002/art.39674

A controlled study of diffuse idiopathic skeletal hyperostosis: Clinical features and functional status, Esdaile, J.M., Chhem, R.K., Rosenberg, E., Gore, B., Watts, C.S., Joseph, L., Starr, M.R., Fitzcharles, M.-A., Fortin, P.R., Mata, S., Medicine, 1997, 10.1097/00005792-199703000-00003

The role of stress in functional disability among women with systemic lupus erythematosus: A prospective study, Clarke, A.E., Esdaile, J.M., Danoff, D.S., Fortin, P.R., Pinard, L., Dobkin, P.L., Da Costa, D., Arthritis Care and Research, 1999, 10.1002/1529-0131(199904)12:2<112::aid-art6>3.0.co;2-2

Evolution of disease burden over five years in a multicenter inception systemic lupus erythematosus cohort, Aranow, C., Kalunian, K., Zoma, A., Stoll, T., Ramos, M., Van Vollenhoven, R.F., Dooley, M.A., Ramsey-Goldman, R., Manzi, S., Petri, M., Khamashta, M., Steinsson, K., Nived, O., Sturfelt, G., Bruce, I.N., Merrill, J.T., Alarcón, G.S., Ginzler, E., Wallace, D.J., Sanchez-Guerrero, J., Rahman, A., Isenberg, D., Hanly, J.G., Bernatsky, S., Clarke, A., Gordon, C., Bae, S.C., Fortin, P.R., Ibañez, D., Gladman, D.D., Urowitz, M.B., Arthritis Care and Research, 2012, 10.1002/acr.20648

Race/ethnicity and cancer occurrence in systemic lupus erythematosus, Ramsey-Goldman, R., Clarke, A., St. Pierre, Y., McCarthy, T., El-Gabalawy, H., Rajan, R., Ensworth, S., Pope, J., Nived, O., Sturfelt, G., Hanly, J., Alarcon, G.S., Dooley, M.A., Aranow, C., Steinsson, K., Rahman, A., Isenberg, D., Sibley, J., Petri, M., Bae, S.C., Edworthy, S., Barr, S., Gordon, C., Fortin, P., Gladman, D., Urowitz, M., Ginzler, E., Manzi, S., Joseph, L., Boivin, J.F., Bernatsky, S., Arthritis Care and Research, 2005, 10.1002/art.21458

Association of autoantibodies to heat-shock protein 60 with arterial vascular events in patients with antiphospholipid antibodies, Rauch, J., Fortin, P.R., Solymoss, S., Kassis, J., Su, J., Landolt-Marticorena, C., Subang, R., Levine, J.S., Pineau, C., Neville, C., Correa, J.A., Dieudé, M., Arthritis and Rheumatism, 2011, 10.1002/art.30411

The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus, Sturfelt, G., Snaith, M., Sanchez-Guerrero, J., Petri, M., Nived, O., Kalunian, K., Isenberg, D.A., Hanly, J.G., Gordon, C., Ginzler, E., Fortin, P., Goldsmith, C.H., Urowitz, M.B., Gladman, D.D., Arthritis and Rheumatism, 1997, 10.1002/art.1780400506

Thromboembolic risk in patients with high titre anticardiolipin and multiple antiphospholipid antibodies, Fortin, P.R., Le Comte, M., Joseph, L., Chang, E.R., Kassis, J., Rauch, J., Neville, C., Thrombosis and Haemostasis, 2003, 10.1055/s-0037-1613606

Determinants of health status in fibromyalgia: A comparative study with systemic lupus erythematosus, Clarke, A.E., Choquette, D., Rich, E., Goulet, J.R., Senécal, J.-L., Zummer, M., Beaulieu, A., Fortin, P.R., Fitzcharles, M.-A., Dobkin, P.L., Da Costa, D., Journal of Rheumatology, 2000

An international cohort study of cancer in systemic lupus erythematosus, Clarke, A., Ramsey-Goldman, R., St. Pierre, Y., McCarthy, T., El-Gabalawy, H., Pope, J., Ensworth, S., Hanly, J., Zummer, M., Senécal, J.L., Alarcón, G., Sturfelt, G., Nived, O., Steinsson, K., Dooley, M.A., Aranow, C., Rahman, A., Isenberg, D., Sibley, J., Bae, S.C., Gordon, C., Barr, S., Edworthy, S., Petri, M., Fortin, P.R., Gladman, D., Urowitz, M., Ginzler, E., Manzi, S., Zoma, A., Rajan, R., Joseph, L., Boivin, J.F., Bernatsky, S., Arthritis and Rheumatism, 2005, 10.1002/art.21029

The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus, Zoma, A., Symmons, D., Sturfelt, G., Snaith, M., Sanchez-Guerrero, J., Richter, M., Petri, M., Nived, O., Maddison, P., Kalunian, K., Jones, J., Isenberg, D., Hay, E., Hanly, J., Bombardieri, S., Bacon, P., Urowitz, M., Liang, M., Fortin, P., Goldsmith, C., Ginzler, E., Gladman, D., Arthritis and Rheumatism, 1996, 10.1002/art.1780390303

Validation of the Social Appearance Anxiety Scale in Patients With Systemic Sclerosis: A Scleroderma Patient-Centered Intervention Network Cohort Study, Turner, K., Pepin, M.R., Cumin, J., Thorne, C., Sutton, E., Steen, V., Smith, D., Robinson, D., Rivière, S., Mekinian, A., Maurier, F., Martin, T., Manning, J., Jones, N., Varga, J., Korman, B., Hinchcliff, M., Herrick, A.L., Sobanski, V., Launay, D., Lambert, M., Hatron, P.-Y., Hachulla, E., Grange, C., Granel-Rey, B., Spiera, R., Gordon, J., Fortin, P.R., Wilcox, P., Dunne, J.V., Domsic, R., Gill, A., Denton, C., Chung, L., Rodriguez, E., Melchor, S., Martin, M., Fare, R., Carreira, P., Berthier, S., Hij, A., Farge-Bancel, D., Benzidia, I., Terrier, B., Régent, A., Paule, R., London, J., Cohen, P., Chaigne, B., Casadevall, M., Benmostefa, N., Roux, S., Masetto, A., Liang, P., Fernandes, A.J.D.B., Dagenais, P., Bruns, A., Boire, G., Bissonnette, L., Arsenault, G., Smets, P., André, M., Ikic, A., Albert, A., Agard, C., Wong-Rieger, D., Welling, J., Suarez-Almazor, M.E., Levis, B., Gyger, G., Steele, R.J., Schouffoer, A.A., Luna, D., Rodriguez Reyna, T.S., Portales, A., Pope, J., Marra, C., Khalidi, N., Larche, M., Kennedy, A.T., Johnson, S.R., Impens, A., Harel, D., Godard, D., Frech, T., Fligelstone, K., van den Ende, C., El-Baalbaki, G., Leite, C., Maia, A.C., Boutron, I., Wigley, F., Nielsen, K., Fortune, C., Sauve, M., Riggs, R., Nielson, W.R., Mouthon, L., Assassi, S., Mayes, M.D., van den Hoogen, F., Kafaja, S., Furst, D., Körner, A., Jang, Y., Hudson, M., Ells, C., Bartlett, S.J., Baron, M., Malcarne, V.L., Thombs, B.D., Roesch, S.C., Gottesman, K., Jewett, L.R., Fox, R.S., Gholizadeh, S., Carrier, M.-E., Kwakkenbos, L., Mills, S.D., Arthritis Care and Research, 2018, 10.1002/acr.23514

Alpha2beta1 integrin (VLA-2) protects activated human effector T cells from methotrexate-induced apoptosis, Aoudjit, F., Fortin, P.R., Naci, D., El Azreq, M.-A., Abderrazak, A., Frontiers in Immunology, 2018, 10.3389/fimmu.2018.02269

Corrigendum: Viewpoint: Response criteria for clinical trials in systemic lupus erythematosus (Lupus (1995) 4 (336-338)), Fortin, P.R., Liang, M.H., Lupus, 1997

A conceptual framework for clinical trials in SLE and other multisystem diseases, Abrahamowicz, M., Esdaile, J.M., Fortin, P., Bae, S.-C., Corzillius, M., Liang, M.H., Lupus, 1999, 10.1191/096120399680411290

Costs of rheumatoid arthritis: New estimates from the human capital method and comparison to the willingness-to-pay method, Penrod, J.R., Donaldson, C., Menard, H.A., Fortin, P.R., Panaritis, T., St-Pierre, Y., Adam, V., Guillemin, F., Clarke, A.E., Fautrel, B., Medical Decision Making, 2007, 10.1177/0272989X06297389

Incidence rates of arterial and venous thrombosis after diagnosis of systemic lupus erythematosus, Fortin, P.R., Urowitz, M., Gladman, D., Ibanez, D., Bobba, R., Chang, E., Sarabi, Z.S., Arthritis Care and Research, 2005, 10.1002/art.21314

Persistent disease activity remains a burden for patients with systemic lupus erythematosus, Fortin, P.R., Wynant, W., Arbillaga, H., Chédeville, G., Avina-Zubieta, A., Smith, C.D., Huber, A.M., Hitchon, C.A., Hudson, M., Levy, D., Pineau, C., Tucker, L., Zummer, M., Ross, J., Iczkovitz, S., Sayani, A., Pope, J., Silverman, E., Abrahamowicz, M., Wang, Y., Peschken, C.A., Journal of Rheumatology, 2019, 10.3899/jrheum.171454

Management of osteoarthritis of the hip and knee, Fortin, P., Liang, M.H., New England Journal of Medicine, 1991, 10.1056/NEJM199107113250210

Association between IgM response to IgG damaged by glyoxidation and disease activity in rheumatoid arthritis, Fortin, P.R., Lepage, K., Neville, C., Newkirk, M.M., Lucey, M.D., Journal of Rheumatology, 2000

Enhanced myelopoiesis and aggravated arthritis in S100a8-deficient mice, Tessier, P.A., Pelletier, M., Aoudjit, F., Labrecque, N., Daudelin, J.-F., Fortin, P.R., Oravecz, T., Al-Shami, A., Tardif, M.R., Pagé, N., Lachhab, A., Defrêne, J., Cesaro, A., PLoS ONE, 2019, 10.1371/journal.pone.0221528

Predictive value of European Scleroderma Group Activity Index in an early scleroderma cohort, Fritzler, M.J., Fortin, P.R., Thorne, C., Smith, D., Rodriguez-Reyna, T.S., Robinson, D., Sutton, E., Masetto, A., Khalidi, N.A., Larché, M.J., Gyger, G., Hudson, M., Pope, J.E., Baron, M., Nevskaya, T., Rheumatology (United Kingdom), 2017, 10.1093/rheumatology/kex015

Intravenous cyclophosphamide and high dose corticosteroids improve MRI lesions in demyelinating syndrome in systemic lupus erythematosus, Fortin, P.R., Leung, F.K., Journal of Rheumatology, 2003

Découvrez nos professeurs et professeures!

Paul R. Fortin

Contribution à la recherche

Projets de recherche

Publications

Contribution à l'enseignement aux cycles supérieurs

Étudiant(e)s dirigé(e)s*

Direction et personnes-ressources